Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Yale University 1987
  • M.P.H., Yale University 1982
• 

  Duke Appointment History

  • Associate Professor of Medicine, Duke Molecular Physiology Institute, Duke Molecular Physiology Institute 2006 - 2015
  • Professor of Community and Family Medicine, Family Medicine and Community Health, Prevention Research, Family Medicine and Community Health 2006 - 2015
  • Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1993 - 2015
  • Assistant Professor in Medicine, Neurology, Clinical Science Departments 1998 - 2006
  • Associate Professor in Community and Family Medicine, Family Medicine and Community Health, Prevention Research, Family Medicine and Community Health 2002 - 2006
  • Associate Professor in Community and Family Medicine, Family Medicine and Community Health, Clinical Science Departments 1998 - 2002
  • Assistant Professor in Community and Family Medicine, Family Medicine and Community Health, Clinical Science Departments 1993 - 1998
• Expertise
• 

  Global Scholarship

  • Research

    • Australia (Country) 
• Research
• 

  Selected Grants

  • Epidemiologic factors and survival by molecular subtypes of ovarian cancer awarded by Fred Hutchinson Cancer Research Center 2013 - 2017
  • Research Training In Neuro-Oncology awarded by National Institutes of Health 1998 - 2016
  • Integrating Population and Basic Science in Cancer Research awarded by National Institutes of Health 2009 - 2015
  • Clinical Oncology Research Career Development Program awarded by National Institutes of Health 2009 - 2015
  • Epidemiology of Ovarian Cancer in African-American Women awarded by National Institutes of Health 2010 - 2015
  • Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers awarded by National Institutes of Health 2011 - 2014
  • Disparities in cervical cancer precursors and deregulation of imprinted genes awarded by National Institutes of Health 2010 - 2014
  • The Molecular Epidemiology Of Ovarian Cancer awarded by National Institutes of Health 1998 - 2012
  • Meningioma: Risk Factors and Quality of Life awarded by National Institutes of Health 2006 - 2012
  • Bayesian Modeling and Optimal Design for Studies of Gene-Environment Association awarded by National Institutes of Health 2007 - 2011
  • Research Training In Neuro-Oncology awarded by National Institutes of Health 2005 - 2010
  • Ovarian Failure Among Hysterectomized Women awarded by National Institutes of Health 2003 - 2010
  • In-utero Exposure and Infant Loss of IGF2 Imprinting awarded by National Institutes of Health 2006 - 2008
  • Carolina and Georgia Genetics Network Center awarded by National Institutes of Health 1998 - 2008
  • Partnerships to Eliminate Disparities in Cancer Outcomes awarded by National Institutes of Health 2002 - 2007
  • The Newborn Epigenetics Study (NEST) awarded by National Institutes of Health 2006
  • Ovarian Cancer Association Consortia awarded by National Institutes of Health 2005
  • CGN Nurse Supplement awarded by National Institutes of Health 1998 - 2004
  • Carolina and Georgia Genetics Network Center awarded by National Institutes of Health 1998 - 2004
  • (CGN Supplement): CGN Ovarian Cancer Screening in High Risk Women Pilot 2 awarded by National Institutes of Health 2001 - 2003
  • Supplement: Inheritance of Colon Cancer: A Sibling Pair Study awarded by National Institutes of Health 1998 - 2003
  • Prostate Cancer Ctr Study: Black Vs White, Va Vs Private. awarded by Department of Veterans Affairs 1998 - 2001
  • Same awarded by National Institutes of Health 1995 - 2001
  • Models Of Personality, Health And Disease In Adulthood awarded by National Institutes of Health 1995 - 1999
  • Models Of Personality, Health, And Disease In Adulthood awarded by National Institutes of Health 1995 - 1999
  • Improving Cancer Risk Communication awarded by National Institutes of Health 1996 - 1999
  • Planning A Program Of Research In Early Breast Cancer awarded by National Institutes of Health 1994 - 1998
  • Spore In Breast Cancer awarded by National Institutes of Health 1995 - 1998
  • Spore In Breast Cancer awarded by National Institutes of Health 1995 - 1998
  • Spore In Breast Cancer awarded by National Institutes of Health 1995 - 1998
  • Molecular Epidemiolgy Of Epithelial Ovarian Cancer awarded by National Institutes of Health 1994 - 1997
  • Molecular Epidemiology Of Epithelial Ovarian Cancer awarded by National Institutes of Health 1994 - 1996
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Bethea, Traci N., Heather M. Ochs-Balcom, Elisa V. Bandera, Alicia Beeghly-Fadiel, Fabian Camacho, Deanna Chyn, Emily K. Cloyd, et al. “First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women.” Int J Cancer 148, no. 12 (June 15, 2021): 2964–73. https://doi.org/10.1002/ijc.33493.
       Full Text  Link to Item
    • Phung, Minh Tung, Alice W. Lee, Anna H. Wu, Andrew Berchuck, Kathleen R. Cho, Daniel W. Cramer, Jennifer Anne Doherty, et al. “Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.” Cancer Epidemiol Biomarkers Prev 30, no. 5 (May 2021): 927–35. https://doi.org/10.1158/1055-9965.EPI-20-1355.
       Full Text  Link to Item
    • Song, Honglin, Ed M. Dicks, Jonathan Tyrer, Maria Intermaggio, Georgia Chenevix-Trench, David D. Bowtell, Nadia Traficante, et al. “Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.” Journal of Medical Genetics 58, no. 5 (May 2021): 305–13. https://doi.org/10.1136/jmedgenet-2019-106739.
       Full Text
    • Lee, Alice W., Stacey Rosenzweig, Ashley Wiensch, Ashley Australian Ovarian Cancer Study Group, Susan J. Ramus, Usha Menon, Aleksandra Gentry-Maharaj, et al. “Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.” J Natl Cancer Inst 113, no. 3 (March 1, 2021): 301–8. https://doi.org/10.1093/jnci/djaa099.
       Full Text  Link to Item
    • Considine, Daniel P. C., Guochong Jia, Xiang Shu, Joellen M. Schildkraut, Paul D. P. Pharoah, Wei Zheng, Siddhartha P. Kar, and Siddhartha P. Ovarian Cancer Association Consortium. “Genetically predicted circulating protein biomarkers and ovarian cancer risk.” Gynecol Oncol 160, no. 2 (February 2021): 506–13. https://doi.org/10.1016/j.ygyno.2020.11.016.
       Full Text  Link to Item
    • Saunders, Charlie N., Alex J. Cornish, Ben Kinnersley, Philip J. Law, Richard S. Houlston, and Richard S. Collaborators. “Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study.” Br J Cancer 124, no. 2 (January 2021): 447–54. https://doi.org/10.1038/s41416-020-01083-1.
       Full Text  Link to Item
    • Modugno, Francesmary, Zhuxuan Fu, Susan J. Jordan, Aocs Group, Jenny Chang-Claude, Renée T. Fortner, Marc T. Goodman, et al. “Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.” Eur J Epidemiol 35, no. 11 (November 2020): 1025–42. https://doi.org/10.1007/s10654-020-00682-9.
       Full Text  Link to Item
    • Staples, Jeanine N., Lauren C. Peres, Fabian Camacho, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa L. Bondy, et al. “Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).” Gynecol Oncol 158, no. 1 (July 2020): 123–29. https://doi.org/10.1016/j.ygyno.2020.04.700.
       Full Text  Link to Item
    • Manichaikul, Ani, Lauren C. Peres, Xin-Qun Wang, Mollie E. Barnard, Deanna Chyn, Xin Sheng, Zhaohui Du, et al. “Identification of novel epithelial ovarian cancer loci in women of African ancestry.” Int J Cancer 146, no. 11 (June 1, 2020): 2987–98. https://doi.org/10.1002/ijc.32653.
       Full Text  Link to Item
    • Babic, Ana, Naoko Sasamoto, Bernard A. Rosner, Shelley S. Tworoger, Susan J. Jordan, Harvey A. Risch, Holly R. Harris, et al. “Association Between Breastfeeding and Ovarian Cancer Risk.” Jama Oncol 6, no. 6 (June 1, 2020): e200421. https://doi.org/10.1001/jamaoncol.2020.0421.
       Full Text  Link to Item
    • Saunders, Charlie N., Alex J. Cornish, Ben Kinnersley, Philip J. Law, Elizabeth B. Claus, Dora Il’yasova, Joellen Schildkraut, et al. “Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis.” Neuro Oncol 22, no. 2 (February 20, 2020): 207–15. https://doi.org/10.1093/neuonc/noz209.
       Full Text  Link to Item
    • Ostrom, Quinn T., Kathleen M. Egan, L Burt Nabors, Travis Gerke, Reid C. Thompson, Jeffrey J. Olson, Renato LaRocca, et al. “Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.” Int J Cancer 146, no. 3 (February 1, 2020): 739–48. https://doi.org/10.1002/ijc.32318.
       Full Text  Link to Item
    • Sjöberg, Rickard L., Wendy Yi-Ying Wu, Anna M. Dahlin, Spiridon Tsavachidis, Spiridon Gliogene Group, Melissa L. Bondy, and Beatrice Melin. “Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study.” J Neurooncol 145, no. 2 (November 2019): 287–94. https://doi.org/10.1007/s11060-019-03294-w.
       Full Text  Link to Item
    • Jiang, Xia, Niki L. Dimou, Kawthar Al-Dabhani, Sarah J. Lewis, Richard M. Martin, Philip C. Haycock, Marc J. Gunter, et al. “Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study.” Int J Epidemiol 48, no. 5 (October 1, 2019): 1416–24. https://doi.org/10.1093/ije/dyy284.
       Full Text  Link to Item
    • Peres, Lauren C., James R. Hebert, Bo Qin, Kristin A. Guertin, Elisa V. Bandera, Nitin Shivappa, Tareq F. Camacho, et al. “Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma.” J Nutr 149, no. 9 (September 1, 2019): 1606–16. https://doi.org/10.1093/jn/nxz098.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Lauren C. Peres, Traci N. Bethea, Fabian Camacho, Deanna Chyn, Emily K. Cloyd, Elisa V. Bandera, et al. “Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.” Cancer Causes Control 30, no. 9 (September 2019): 967–78. https://doi.org/10.1007/s10552-019-01199-7.
       Full Text  Link to Item
    • Reid, Brett M., Jennifer B. Permuth, Y Ann Chen, Brooke L. Fridley, Edwin S. Iversen, Zhihua Chen, Heather Jim, et al. “Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.” Cancer Epidemiol Biomarkers Prev 28, no. 7 (July 2019): 1117–26. https://doi.org/10.1158/1055-9965.EPI-18-0833.
       Full Text  Link to Item
    • Harris, Holly R., Kara L. Cushing-Haugen, Penelope M. Webb, Christina M. Nagle, Susan J. Jordan, Susan J. Australian Ovarian Cancer Study Group, Harvey A. Risch, et al. “Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.” Int J Epidemiol 48, no. 3 (June 1, 2019): 822–30. https://doi.org/10.1093/ije/dyz113.
       Full Text  Link to Item
    • Takahashi, Hannah, Alex J. Cornish, Amit Sud, Philip J. Law, Ben Kinnersley, Quinn T. Ostrom, Karim Labreche, et al. “Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma.” Sci Rep 9, no. 1 (May 23, 2019): 7924. https://doi.org/10.1038/s41598-019-43787-2.
       Full Text  Link to Item
    • Muskens, Ivo S., Helen M. Hansen, Ivan V. Smirnov, Annette M. Molinaro, Melissa L. Bondy, Joellen M. Schildkraut, Margaret Wrensch, Joseph L. Wiemels, and Elizabeth B. Claus. “Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.” J Neurooncol 142, no. 3 (May 2019): 479–87. https://doi.org/10.1007/s11060-019-03119-w.
       Full Text  Link to Item
    • Kim, Sehee, Miao Wang, Jonathan P. Tyrer, Allan Jensen, Ashley Wiensch, Gang Liu, Alice W. Lee, et al. “A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.” International Journal of Cancer 144, no. 9 (May 2019): 2192–2205. https://doi.org/10.1002/ijc.32029.
       Full Text
    • Moorman, Patricia G., Nadine J. Barrett, Frances Wang, J Anthony Alberg, Elisa V. Bandera, J. B. Barnholtz-Sloan, Melissa Bondy, et al. “Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women.” J Womens Health (Larchmt) 28, no. 4 (April 2019): 444–51. https://doi.org/10.1089/jwh.2018.7031.
       Full Text  Link to Item
    • Amirian, E Susan, Quinn T. Ostrom, Georgina N. Armstrong, Rose K. Lai, Xiangjun Gu, Daniel I. Jacobs, Ali Jalali, et al. “Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis.” Cancer Epidemiol Biomarkers Prev 28, no. 3 (March 2019): 555–62. https://doi.org/10.1158/1055-9965.EPI-18-0702.
       Full Text  Link to Item
    • Mills, Anne M., Lauren C. Peres, Alice Meiss, Kari L. Ring, Susan C. Modesitt, Sarah E. Abbott, Anthony J. Alberg, et al. “Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).” Int J Gynecol Pathol 38, no. 2 (March 2019): 157–70. https://doi.org/10.1097/PGP.0000000000000494.
       Full Text  Link to Item
    • Anderson, Roger T., Lauren C. Peres, Fabian Camacho, Elisa V. Bandera, Ellen Funkhouser, Patricia G. Moorman, Lisa E. Paddock, et al. “Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study.” J Womens Health (Larchmt) 28, no. 2 (February 2019): 284–93. https://doi.org/10.1089/jwh.2018.7025.
       Full Text  Link to Item
    • Yang, Yaohua, Lang Wu, Xiang Shu, Yingchang Lu, Xiao-Ou Shu, Qiuyin Cai, Alicia Beeghly-Fadiel, et al. “Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.” Cancer Res 79, no. 3 (February 1, 2019): 505–17. https://doi.org/10.1158/0008-5472.CAN-18-2726.
       Full Text  Link to Item
    • Takahashi, Hannah, Alex J. Cornish, Amit Sud, Philip J. Law, Linden Disney-Hogg, Lisa Calvocoressi, Lingeng Lu, et al. “Mendelian randomization provides support for obesity as a risk factor for meningioma.” Sci Rep 9, no. 1 (January 22, 2019): 309. https://doi.org/10.1038/s41598-018-36186-6.
       Full Text  Link to Item
    • Ostrom, Quinn T., Warren Coleman, William Huang, Joshua B. Rubin, Justin D. Lathia, Michael E. Berens, Gil Speyer, et al. “Sex-specific gene and pathway modeling of inherited glioma risk.” Neuro Oncol 21, no. 1 (January 1, 2019): 71–82. https://doi.org/10.1093/neuonc/noy135.
       Full Text  Link to Item
    • Peres, Lauren C., Kara L. Cushing-Haugen, Martin Köbel, Holly R. Harris, Andrew Berchuck, Mary Anne Rossing, Joellen M. Schildkraut, and Jennifer A. Doherty. “Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.” J Natl Cancer Inst 111, no. 1 (January 1, 2019): 60–68. https://doi.org/10.1093/jnci/djy071.
       Full Text  Link to Item
    • Ostrom, Quinn T., Ben Kinnersley, Georgina Armstrong, Terri Rice, Yanwen Chen, John K. Wiencke, Lucie S. McCoy, et al. “Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.” Int J Cancer 143, no. 10 (November 15, 2018): 2359–66. https://doi.org/10.1002/ijc.31759.
       Full Text  Link to Item
    • Park, Hyo K., Joellen M. Schildkraut, Anthony J. Alberg, Elisa V. Bandera, Jill S. Barnholtz-Sloan, Melissa Bondy, Sydnee Crankshaw, et al. “Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study.” Cancer Causes Control 29, no. 11 (November 2018): 1081–91. https://doi.org/10.1007/s10552-018-1082-4.
       Full Text  Link to Item
    • Claus, Elizabeth B., Alex J. Cornish, Peter Broderick, Joellen M. Schildkraut, Sara E. Dobbins, Amy Holroyd, Lisa Calvocoressi, et al. “Genome-wide association analysis identifies a meningioma risk locus at 11p15.5.” Neuro Oncol 20, no. 11 (October 9, 2018): 1485–93. https://doi.org/10.1093/neuonc/noy077.
       Full Text  Link to Item
    • Peres, Lauren C., Kara L. Cushing-Haugen, Michael Anglesio, Kristine Wicklund, Rex Bentley, Andrew Berchuck, Linda E. Kelemen, et al. “Histotype classification of ovarian carcinoma: A comparison of approaches.” Gynecol Oncol 151, no. 1 (October 2018): 53–60. https://doi.org/10.1016/j.ygyno.2018.08.016.
       Full Text  Link to Item
    • Rambau, Peter F., Robert A. Vierkant, Maria P. Intermaggio, Linda E. Kelemen, Marc T. Goodman, Esther Herpel, Paul D. Pharoah, et al. “Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.” J Pathol Clin Res 4, no. 4 (October 2018): 250–61. https://doi.org/10.1002/cjp2.109.
       Full Text  Link to Item
    • Lu, Yingchang, Alicia Beeghly-Fadiel, Lang Wu, Xingyi Guo, Bingshan Li, Joellen M. Schildkraut, Hae Kyung Im, et al. “A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.” Cancer Res 78, no. 18 (September 15, 2018): 5419–30. https://doi.org/10.1158/0008-5472.CAN-18-0951.
       Full Text  Link to Item
    • Kelemen, Linda E., Madalene Earp, Brooke L. Fridley, Georgia Chenevix-Trench, Georgia Australian Ovarian Cancer Study Group, Peter A. Fasching, Matthias W. Beckmann, et al. “rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.” Int J Mol Sci 19, no. 9 (August 21, 2018). https://doi.org/10.3390/ijms19092473.
       Full Text  Link to Item
    • Qin, Bo, Lauren C. Peres, Joellen M. Schildkraut, and Elisa V. Bandera. “Reply to 'Comment on 'Dairy, calcium, vitamin D and ovarian cancer risk in African-American women''.” Br J Cancer 119, no. 2 (July 2018): 260–62. https://doi.org/10.1038/s41416-018-0163-1.
       Full Text  Link to Item
    • Peres, Lauren C., Harvey Risch, Kathryn L. Terry, Penelope M. Webb, Marc T. Goodman, Anna H. Wu, Anthony J. Alberg, et al. “Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.” Int J Epidemiol 47, no. 3 (June 1, 2018): 1011. https://doi.org/10.1093/ije/dyy054.
       Full Text  Link to Item
    • Berntsson, Shala G., Ryan T. Merrell, E Susan Amirian, Georgina N. Armstrong, Daniel Lachance, Anja Smits, Renke Zhou, et al. “Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case-control study.” J Neurol 265, no. 6 (June 2018): 1432–42. https://doi.org/10.1007/s00415-018-8857-0.
       Full Text  Link to Item
    • Ostrom, Quinn T., Ben Kinnersley, Margaret R. Wrensch, Jeanette E. Eckel-Passow, Georgina Armstrong, Terri Rice, Yanwen Chen, et al. “Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.” Sci Rep 8, no. 1 (May 9, 2018): 7352. https://doi.org/10.1038/s41598-018-24580-z.
       Full Text  Link to Item
    • Benjamin Neelon, S. E., A. J. White, A. C. Vidal, J. M. Schildkraut, A. P. Murtha, S. K. Murphy, S. W. Kullman, and C. Hoyo. “Maternal vitamin D, DNA methylation at imprint regulatory regions and offspring weight at birth, 1 year and 3 years.” Int J Obes (Lond) 42, no. 4 (April 2018): 587–93. https://doi.org/10.1038/ijo.2017.160.
       Full Text  Link to Item
    • Disney-Hogg, Linden, Amit Sud, Philip J. Law, Alex J. Cornish, Ben Kinnersley, Quinn T. Ostrom, Karim Labreche, et al. “Influence of obesity-related risk factors in the aetiology of glioma.” Br J Cancer 118, no. 7 (April 2018): 1020–27. https://doi.org/10.1038/s41416-018-0009-x.
       Full Text  Link to Item
    • Dixon-Suen, Suzanne C., Christina M. Nagle, Aaron P. Thrift, Paul D. P. Pharoah, Ailith Ewing, Celeste Leigh Pearce, Wei Zheng, et al. “Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.” Br J Cancer 118, no. 8 (April 2018): 1123–29. https://doi.org/10.1038/s41416-018-0011-3.
       Full Text  Link to Item
    • Kar, Siddhartha P., Andrew Berchuck, Simon A. Gayther, Ellen L. Goode, Kirsten B. Moysich, Celeste Leigh Pearce, Susan J. Ramus, Joellen M. Schildkraut, Thomas A. Sellers, and Paul D. P. Pharoah. “Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions.” Cancer Epidemiol Biomarkers Prev 27, no. 4 (April 2018): 395–404. https://doi.org/10.1158/1055-9965.EPI-17-0315.
       Full Text  Link to Item
    • Ong, Jue-Sheng, Liang-Dar Hwang, Gabriel Cuellar-Partida, Nicholas G. Martin, Georgia Chenevix-Trench, Michael C. J. Quinn, Marilyn C. Cornelis, et al. “Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study.” Int J Epidemiol 47, no. 2 (April 1, 2018): 450–59. https://doi.org/10.1093/ije/dyx236.
       Full Text  Link to Item
    • Tarney, Christopher M., Chunqiao Tian, Guisong Wang, Elizabeth A. Dubil, Nicholas W. Bateman, John K. Chan, Mohamed A. Elshaikh, et al. “Impact of age at diagnosis on racial disparities in endometrial cancer patients.” Gynecol Oncol 149, no. 1 (April 2018): 12–21. https://doi.org/10.1016/j.ygyno.2017.07.145.
       Full Text  Link to Item
    • Peres, Lauren C., Harvey Risch, Kathryn L. Terry, Penelope M. Webb, Marc T. Goodman, Anna H. Wu, Anthony J. Alberg, et al. “Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.” International Journal of Epidemiology 47, no. 2 (April 2018): 460–72. https://doi.org/10.1093/ije/dyx252.
       Full Text
    • Disney-Hogg, Linden, Alex J. Cornish, Amit Sud, Philip J. Law, Ben Kinnersley, Daniel I. Jacobs, Quinn T. Ostrom, et al. “Impact of atopy on risk of glioma: a Mendelian randomisation study.” Bmc Med 16, no. 1 (March 15, 2018): 42. https://doi.org/10.1186/s12916-018-1027-5.
       Full Text  Link to Item
    • Takahashi, Hannah, Alex J. Cornish, Amit Sud, Philip J. Law, Ben Kinnersley, Quinn T. Ostrom, Karim Labreche, et al. “Mendelian randomisation study of the relationship between vitamin D and risk of glioma.” Sci Rep 8, no. 1 (February 5, 2018): 2339. https://doi.org/10.1038/s41598-018-20844-w.
       Full Text  Link to Item
    • Harris, Holly R., Ana Babic, Penelope M. Webb, Christina M. Nagle, Susan J. Jordan, Harvey A. Risch, Mary Anne Rossing, et al. “Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.” Cancer Epidemiol Biomarkers Prev 27, no. 2 (February 2018): 174–82. https://doi.org/10.1158/1055-9965.EPI-17-0655.
       Full Text  Link to Item
    • Liu, Gang, Bhramar Mukherjee, Seunggeun Lee, Alice W. Lee, Anna H. Wu, Elisa V. Bandera, Allan Jensen, et al. “Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.” Am J Epidemiol 187, no. 2 (February 1, 2018): 366–77. https://doi.org/10.1093/aje/kwx243.
       Full Text  Link to Item
    • Babic, Ana, Holly R. Harris, Allison F. Vitonis, Linda J. Titus, Susan J. Jordan, Penelope M. Webb, Penelope M. Australian Ovarian Cancer Study Group, et al. “Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium.” Int J Cancer 142, no. 3 (February 1, 2018): 460–69. https://doi.org/10.1002/ijc.31010.
       Full Text  Link to Item
    • Ugai, Tomotaka, Linda E. Kelemen, Mika Mizuno, Jue-Sheng Ong, Penelope M. Webb, Georgia Chenevix-Trench, Georgia Australian Ovarian Cancer Study Group, et al. “Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium.” Cancer Science 109, no. 2 (February 2018): 435–45. https://doi.org/10.1111/cas.13470.
       Full Text
    • Earp, Madalene, Jonathan P. Tyrer, Stacey J. Winham, Hui-Yi Lin, Ganna Chornokur, Joe Dennis, Katja K. H. Aben, et al. “Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.” Plos One 13, no. 7 (2018): e0197561. https://doi.org/10.1371/journal.pone.0197561.
       Full Text  Link to Item
    • Abbott, Sarah E., Fabian Camacho, Lauren C. Peres, Anthony J. Alberg, Elisa V. Bandera, Melissa Bondy, Michele L. Cote, et al. “Recreational physical activity and survival in African-American women with ovarian cancer.” Cancer Causes & Control : Ccc 29, no. 1 (January 2018): 77–86. https://doi.org/10.1007/s10552-017-0986-8.
       Full Text
    • Benz, Luke S., Margaret R. Wrensch, Joellen M. Schildkraut, Melissa L. Bondy, Joshua L. Warren, Joseph L. Wiemels, and Elizabeth B. Claus. “Quality of life after surgery for intracranial meningioma.” Cancer 124, no. 1 (January 2018): 161–66. https://doi.org/10.1002/cncr.30975.
       Full Text
    • Dimitrakopoulou, Vasiliki I., Konstantinos K. Tsilidis, Philip C. Haycock, Niki L. Dimou, Kawthar Al-Dabhani, Richard M. Martin, Sarah J. Lewis, et al. “Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.” Bmj 359 (October 31, 2017): j4761. https://doi.org/10.1136/bmj.j4761.
       Full Text  Link to Item
    • Epidemiology Working Group Steering Committee, Ovarian Cancer Association Consortium Members of the EWG SC, in alphabetical order:, Nicolas, Jennifer A. Doherty, Allan Jensen, Linda E. Kelemen, Celeste L. Pearce, Elizabeth Poole, Joellen M. Schildkraut, et al. “Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research.” J Natl Cancer Inst 109, no. 10 (October 1, 2017). https://doi.org/10.1093/jnci/djx144.
       Full Text  Link to Item
    • McNamara, Chrissy, Sarah E. Abbott, Elisa V. Bandera, Bo Qin, Lauren C. Peres, Fabian Camacho, Patricia G. Moorman, et al. “Tubal ligation and ovarian cancer risk in African American women.” Cancer Causes Control 28, no. 10 (October 2017): 1033–41. https://doi.org/10.1007/s10552-017-0943-6.
       Full Text  Link to Item
    • Minlikeeva, Albina N., Jo L. Freudenheim, Rikki A. Cannioto, Kevin H. Eng, J Brian Szender, Paul Mayor, John L. Etter, et al. “History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.” Br J Cancer 117, no. 7 (September 26, 2017): 1063–69. https://doi.org/10.1038/bjc.2017.267.
       Full Text  Link to Item
    • Mechanic, Leah E., Sara Lindström, Kenneth M. Daily, Solveig K. Sieberts, Christopher I. Amos, Huann-Sheng Chen, Nancy J. Cox, et al. “Up For A Challenge (U4C): Stimulating innovation in breast cancer genetic epidemiology.” Plos Genet 13, no. 9 (September 2017): e1006945. https://doi.org/10.1371/journal.pgen.1006945.
       Full Text  Link to Item
    • Minlikeeva, Albina N., Jo L. Freudenheim, Kevin H. Eng, Rikki A. Cannioto, Grace Friel, J Brian Szender, Brahm Segal, et al. “History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.” Cancer Epidemiol Biomarkers Prev 26, no. 9 (September 2017): 1470–73. https://doi.org/10.1158/1055-9965.EPI-17-0367.
       Full Text  Link to Item
    • Akbari, Mohammad R., Shiyu Zhang, Deborah Cragun, Ji-Hyun Lee, Domenico Coppola, John McLaughlin, Harvey A. Risch, et al. “Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens.” Fam Cancer 16, no. 3 (July 2017): 351–55. https://doi.org/10.1007/s10689-017-9973-1.
       Full Text  Link to Item
    • Kelemen, Linda E., Sarah Abbott, Bo Qin, Lauren Cole Peres, Patricia G. Moorman, Kristin Wallace, Elisa V. Bandera, et al. “Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES).” Cancer Causes Control 28, no. 7 (July 2017): 699–708. https://doi.org/10.1007/s10552-017-0899-6.
       Full Text  Link to Item
    • Peres, Lauren C., Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.” American Journal of Epidemiology 186, no. 1 (July 2017): 46–53. https://doi.org/10.1093/aje/kwx055.
       Full Text
    • Glubb, Dylan M., Sharon E. Johnatty, Michael C. J. Quinn, Tracy A. O’Mara, Jonathan P. Tyrer, Bo Gao, Peter A. Fasching, et al. “Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.” Oncotarget, June 15, 2017. https://doi.org/10.18632/oncotarget.18501.
       Full Text  Link to Item
    • Qin, Bo, Patricia G. Moorman, Linda E. Kelemen, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, et al. “Dietary Quality and Ovarian Cancer Risk in African-American Women.” Am J Epidemiol 185, no. 12 (June 15, 2017): 1281–89. https://doi.org/10.1093/aje/kwx022.
       Full Text  Link to Item
    • Praestegaard, Camilla, Allan Jensen, Signe M. Jensen, Thor S. S. Nielsen, Penelope M. Webb, Christina M. Nagle, Anna DeFazio, et al. “Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.” Int J Cancer 140, no. 11 (June 1, 2017): 2422–35. https://doi.org/10.1002/ijc.30600.
       Full Text  Link to Item
    • Cannioto, Rikki A., Britton Trabert, Elizabeth M. Poole, and Joellen M. Schildkraut. “Ovarian cancer epidemiology in the era of collaborative team science.” Cancer Causes Control 28, no. 5 (May 2017): 487–95. https://doi.org/10.1007/s10552-017-0862-6.
       Full Text  Link to Item
    • Minlikeeva, Albina N., Jo L. Freudenheim, Rikki A. Cannioto, J Brian Szender, Kevin H. Eng, Francesmary Modugno, Roberta B. Ness, et al. “History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.” Cancer Causes Control 28, no. 5 (May 2017): 469–86. https://doi.org/10.1007/s10552-017-0867-1.
       Full Text  Link to Item
    • Phelan, Catherine M., Karoline B. Kuchenbaecker, Jonathan P. Tyrer, Siddhartha P. Kar, Kate Lawrenson, Stacey J. Winham, Joe Dennis, et al. “Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.” Nat Genet 49, no. 5 (May 2017): 680–91. https://doi.org/10.1038/ng.3826.
       Full Text  Link to Item
    • Peres, Lauren C., Patricia G. Moorman, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, et al. “Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.” Cancer Causes & Control : Ccc 28, no. 5 (May 2017): 405–14. https://doi.org/10.1007/s10552-017-0853-7.
       Full Text
    • Dixon, Suzanne C., Christina M. Nagle, Nicolas Wentzensen, Britton Trabert, Alicia Beeghly-Fadiel, Joellen M. Schildkraut, Kirsten B. Moysich, et al. “Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.” Br J Cancer 116, no. 9 (April 25, 2017): 1223–28. https://doi.org/10.1038/bjc.2017.68.
       Full Text  Link to Item
    • Terry, Paul D., Bo Qin, Fabian Camacho, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, et al. “Supplemental Selenium May Decrease Ovarian Cancer Risk in African-American Women.” J Nutr 147, no. 4 (April 2017): 621–27. https://doi.org/10.3945/jn.116.243279.
       Full Text  Link to Item
    • Sucheston-Campbell, Lara E., Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, et al. “No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.” Cancer Epidemiol Biomarkers Prev 26, no. 3 (March 2017): 420–24. https://doi.org/10.1158/1055-9965.EPI-16-0631.
       Full Text  Link to Item
    • Kar, Siddhartha P., Emily Adler, Jonathan Tyrer, Dennis Hazelett, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, et al. “Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.” Br J Cancer 116, no. 4 (February 14, 2017): 524–35. https://doi.org/10.1038/bjc.2016.426.
       Full Text  Link to Item
    • Peres, Lauren C., Elisa V. Bandera, Bo Qin, Kristin A. Guertin, Nitin Shivappa, James R. Hebert, Sarah E. Abbott, et al. “Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.” Int J Cancer 140, no. 3 (February 1, 2017): 535–43. https://doi.org/10.1002/ijc.30467.
       Full Text  Link to Item
    • Buchanan, Adam H., Corrine I. Voils, Joellen M. Schildkraut, Catherine Fine, Nora K. Horick, P Kelly Marcom, Kristi Wiggins, and Celette Sugg Skinner. “Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.” J Genet Couns 26, no. 1 (February 2017): 79–92. https://doi.org/10.1007/s10897-016-9981-6.
       Full Text  Link to Item
    • Reid, Brett M., Jennifer B. Permuth, Y Ann Chen, Jamie K. Teer, Alvaro N. A. Monteiro, Zhihua Chen, Jonathan Tyrer, et al. “Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.” Cancer Epidemiol Biomarkers Prev 26, no. 1 (January 2017): 116–25. https://doi.org/10.1158/1055-9965.EPI-16-0341.
       Full Text  Link to Item
    • Rasmussen, Christina B., Susanne K. Kjaer, Vanna Albieri, Elisa V. Bandera, Jennifer A. Doherty, Estrid Høgdall, Penelope M. Webb, et al. “Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.” Am J Epidemiol 185, no. 1 (January 1, 2017): 8–20. https://doi.org/10.1093/aje/kww161.
       Full Text  Link to Item
    • Karami, Sara, Younghun Han, Mala Pande, Iona Cheng, James Rudd, Brandon L. Pierce, Ellen L. Nutter, et al. “Telomere structure and maintenance gene variants and risk of five cancer types.” Int J Cancer 139, no. 12 (December 15, 2016): 2655–70. https://doi.org/10.1002/ijc.30288.
       Full Text  Link to Item
    • Lee, Alice W., Ashley Bomkamp, Elisa V. Bandera, Allan Jensen, Susan J. Ramus, Marc T. Goodman, Mary Anne Rossing, et al. “A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.” Int J Cancer 139, no. 12 (December 15, 2016): 2646–54. https://doi.org/10.1002/ijc.30274.
       Full Text  Link to Item
    • Southey, Melissa C., David E. Goldgar, Robert Winqvist, Katri Pylkäs, Fergus Couch, Marc Tischkowitz, William D. Foulkes, et al. “PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.” J Med Genet 53, no. 12 (December 2016): 800–811. https://doi.org/10.1136/jmedgenet-2016-103839.
       Full Text  Link to Item
    • Permuth, Jennifer B., Brett Reid, Madalene Earp, Y Ann Chen, Alvaro N. A. Monteiro, Zhihua Chen, Zhihua AOCS Study Group, et al. “Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.” Oncotarget 7, no. 45 (November 8, 2016): 72381–94. https://doi.org/10.18632/oncotarget.10546.
       Full Text  Link to Item
    • Hampras, Shalaka S., Lara E. Sucheston-Campbell, Rikki Cannioto, Jenny Chang-Claude, Francesmary Modugno, Thilo Dörk, Peter Hillemanns, et al. “Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.” Oncotarget 7, no. 43 (October 25, 2016): 69097–110. https://doi.org/10.18632/oncotarget.10215.
       Full Text  Link to Item
    • Qin, Bo, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Dairy, calcium, vitamin D and ovarian cancer risk in African-American women.” Br J Cancer 115, no. 9 (October 25, 2016): 1122–30. https://doi.org/10.1038/bjc.2016.289.
       Full Text  Link to Item
    • Clyde, Merlise A., Rachel Palmieri Weber, Edwin S. Iversen, Elizabeth M. Poole, Jennifer A. Doherty, Marc T. Goodman, Roberta B. Ness, et al. “Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.” Am J Epidemiol 184, no. 8 (October 15, 2016): 579–89. https://doi.org/10.1093/aje/kww091.
       Full Text  Open Access Copy  Link to Item
    • Ong, Jue-Sheng, Gabriel Cuellar-Partida, Yi Lu, Yi Australian Ovarian Cancer Study, Peter A. Fasching, Alexander Hein, Stefanie Burghaus, et al. “Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.” Int J Epidemiol 45, no. 5 (October 2016): 1619–30. https://doi.org/10.1093/ije/dyw207.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Sarah E. Abbott, Anthony J. Alberg, Elisa V. Bandera, Jill S. Barnholtz-Sloan, Melissa L. Bondy, Michele L. Cote, et al. “Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).” Cancer Epidemiol Biomarkers Prev 25, no. 10 (October 2016): 1411–17. https://doi.org/10.1158/1055-9965.EPI-15-1281.
       Full Text  Link to Item
    • Lawrenson, Kate, Siddhartha Kar, Karen McCue, Karoline Kuchenbaeker, Kyriaki Michailidou, Jonathan Tyrer, Jonathan Beesley, et al. “Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.” Nat Commun 7 (September 7, 2016): 12675. https://doi.org/10.1038/ncomms12675.
       Full Text  Link to Item
    • Cannioto, R., M. J. LaMonte, H. A. Risch, C. C. Hong, L. E. Sucheston-Campbell, K. H. Eng, J. B. Szender, et al. “Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.” Obstetrical and Gynecological Survey 71, no. 9 (September 1, 2016): 528–30. https://doi.org/10.1097/OGX.0000000000000357.
       Full Text
    • Fehringer, Gordon, Peter Kraft, Paul D. Pharoah, Rosalind A. Eeles, Nilanjan Chatterjee, Fredrick R. Schumacher, Joellen M. Schildkraut, et al. “Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.” Cancer Res 76, no. 17 (September 1, 2016): 5103–14. https://doi.org/10.1158/0008-5472.CAN-15-2980.
       Full Text  Link to Item
    • Kar, Siddhartha P., Jonathan Beesley, Ali Amin Al Olama, Kyriaki Michailidou, Jonathan Tyrer, ZSofia Kote-Jarai, Kate Lawrenson, et al. “Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.” Cancer Discov 6, no. 9 (September 2016): 1052–67. https://doi.org/10.1158/2159-8290.CD-15-1227.
       Full Text  Link to Item
    • Moorman, Patricia G., Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Reproductive factors and ovarian cancer risk in African-American women.” Ann Epidemiol 26, no. 9 (September 2016): 654–62. https://doi.org/10.1016/j.annepidem.2016.07.004.
       Full Text  Link to Item
    • Khankari, Nikhil K., Xiao-Ou Shu, Wanqing Wen, Peter Kraft, Sara Lindström, Ulrike Peters, Joellen Schildkraut, et al. “Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.” Plos Med 13, no. 9 (September 2016): e1002118. https://doi.org/10.1371/journal.pmed.1002118.
       Full Text  Link to Item
    • Alberg, Anthony J., Patricia G. Moorman, Sydnee Crankshaw, Frances Wang, Elisa V. Bandera, Jill S. Barnholtz-Sloan, Melissa Bondy, et al. “Socioeconomic Status in Relation to the Risk of Ovarian Cancer in African-American Women: A Population-Based Case-Control Study.” Am J Epidemiol 184, no. 4 (August 15, 2016): 274–83. https://doi.org/10.1093/aje/kwv450.
       Full Text  Link to Item
    • Permuth, Jennifer B., Ailith Pirie, Y. Ann Chen, Hui-Yi Lin, Brett M. Reid, Zhihua Chen, Alvaro Monteiro, et al. “Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.” Hum Mol Genet 25, no. 16 (August 15, 2016): 3600–3612. https://doi.org/10.1093/hmg/ddw196.
       Full Text  Link to Item
    • Bandera, Elisa V., Bo Qin, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, et al. “Obesity, weight gain, and ovarian cancer risk in African American women.” Int J Cancer 139, no. 3 (August 1, 2016): 593–600. https://doi.org/10.1002/ijc.30115.
       Full Text  Link to Item
    • Lee, A. W., R. B. Ness, L. D. Roman, K. L. Terry, J. M. Schildkraut, J. Chang-Claude, J. A. Doherty, et al. “Association between menopausal estrogen-only therapy and ovarian carcinoma risk.” Obstetrical and Gynecological Survey 71, no. 8 (August 1, 2016): 470–71. https://doi.org/10.1097/01.ogx.0000489579.62561.b8.
       Full Text
    • Cannioto, Rikki, Michael J. LaMonte, Harvey A. Risch, Chi-Chen Hong, Lara E. Sucheston-Campbell, Kevin H. Eng, J. Brian Szender, et al. “Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.” Cancer Epidemiol Biomarkers Prev 25, no. 7 (July 2016): 1114–24. https://doi.org/10.1158/1055-9965.EPI-15-1330.
       Full Text  Link to Item
    • Cuellar-Partida, Gabriel, Yi Lu, Suzanne C. Dixon, Suzanne C. Australian Ovarian Cancer Study, Peter A. Fasching, Alexander Hein, Stefanie Burghaus, et al. “Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.” Hum Genet 135, no. 7 (July 2016): 741–56. https://doi.org/10.1007/s00439-016-1663-9.
       Full Text  Link to Item
    • Cannioto, Rikki A., Michael J. LaMonte, Linda E. Kelemen, Harvey A. Risch, Kevin H. Eng, Albina N. Minlikeeva, Chi-Chen Hong, et al. “Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.” Br J Cancer 115, no. 1 (June 28, 2016): 95–101. https://doi.org/10.1038/bjc.2016.153.
       Full Text  Link to Item
    • Abbott, Sarah E., Elisa V. Bandera, Bo Qin, Lauren C. Peres, Patricia G. Moorman, Jill Barnholtz-Sloan, Ann G. Schwartz, et al. “Recreational physical activity and ovarian cancer risk in African American women.” Cancer Med 5, no. 6 (June 2016): 1319–27. https://doi.org/10.1002/cam4.677.
       Full Text  Link to Item
    • Amirian, E Susan, Michael E. Scheurer, Renke Zhou, Margaret R. Wrensch, Georgina N. Armstrong, Daniel Lachance, Sara H. Olson, et al. “History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC).” Cancer Med 5, no. 6 (June 2016): 1352–58. https://doi.org/10.1002/cam4.682.
       Full Text  Link to Item
    • Dixon, Suzanne C., Christina M. Nagle, Aaron P. Thrift, Paul Dp Pharoah, Celeste Leigh Pearce, Wei Zheng, Jodie N. Painter, et al. “Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.” Int J Epidemiol 45, no. 3 (June 2016): 884–95. https://doi.org/10.1093/ije/dyw158.
       Full Text  Link to Item
    • Erondu, Chioma O., Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer.” J Womens Health (Larchmt) 25, no. 6 (June 2016): 571–78. https://doi.org/10.1089/jwh.2015.5359.
       Full Text  Link to Item
    • Gao, Chi, Chirag J. Patel, Kyriaki Michailidou, Ulrike Peters, Jian Gong, Joellen Schildkraut, Fredrick R. Schumacher, et al. “Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer.” Int J Epidemiol 45, no. 3 (June 2016): 896–908. https://doi.org/10.1093/ije/dyw129.
       Full Text  Link to Item
    • Lee, Alice W., Roberta B. Ness, Lynda D. Roman, Kathryn L. Terry, Joellen M. Schildkraut, Jenny Chang-Claude, Jennifer A. Doherty, et al. “Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.” Obstet Gynecol 127, no. 5 (May 2016): 828–36. https://doi.org/10.1097/AOG.0000000000001387.
       Full Text  Link to Item
    • Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, Ellen L., Antoinette Hollestelle, Frederieke H. van der Baan, Andrew Berchuck, Sharon E. Johnatty, Katja K. Aben, Bjarni A. Agnarsson, et al. “No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.” Gynecol Oncol 141, no. 2 (May 2016): 386–401. https://doi.org/10.1016/j.ygyno.2015.04.034.
       Full Text  Link to Item
    • Usset, Joseph L., Rama Raghavan, Jonathan P. Tyrer, Valerie McGuire, Weiva Sieh, Penelope Webb, Jenny Chang-Claude, et al. “Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.” Cancer Epidemiol Biomarkers Prev 25, no. 5 (May 2016): 780–90. https://doi.org/10.1158/1055-9965.EPI-15-1039.
       Full Text  Link to Item
    • Præstegaard, Camilla, Susanne K. Kjaer, Thor S. S. Nielsen, Signe M. Jensen, Penelope M. Webb, Christina M. Nagle, Estrid Høgdall, et al. “The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies.” Cancer Epidemiology 41 (April 2016): 71–79. https://doi.org/10.1016/j.canep.2016.01.012.
       Full Text
    • Peres, Lauren C., Fabian Camacho, Sarah E. Abbott, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, et al. “Analgesic medication use and risk of epithelial ovarian cancer in African American women.” Br J Cancer 114, no. 7 (March 29, 2016): 819–25. https://doi.org/10.1038/bjc.2016.39.
       Full Text  Link to Item
    • Winham, Stacey J., Ailith Pirie, Yian Ann Chen, Melissa C. Larson, Zachary C. Fogarty, Madalene A. Earp, Hoda Anton-Culver, et al. “Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.” Cancer Epidemiol Biomarkers Prev 25, no. 3 (March 2016): 446–54. https://doi.org/10.1158/1055-9965.EPI-15-0240.
       Full Text  Link to Item
    • Qin, Bo, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women.” Br J Nutr 115, no. 4 (February 28, 2016): 694–702. https://doi.org/10.1017/S0007114515004882.
       Full Text  Link to Item
    • Earp, Madalene, Stacey J. Winham, Nicholas Larson, Jennifer B. Permuth, Hugues Sicotte, Jeremy Chien, Hoda Anton-Culver, et al. “A targeted genetic association study of epithelial ovarian cancer susceptibility.” Oncotarget 7, no. 7 (February 16, 2016): 7381–89. https://doi.org/10.18632/oncotarget.7121.
       Full Text  Link to Item
    • French, Juliet D., Sharon E. Johnatty, Yi Lu, Jonathan Beesley, Bo Gao, Murugan Kalimutho, Michelle J. Henderson, et al. “Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.” Oncotarget 7, no. 6 (February 9, 2016): 6353–68. https://doi.org/10.18632/oncotarget.7047.
       Full Text  Link to Item
    • Amirian, E Susan, Renke Zhou, Margaret R. Wrensch, Sara H. Olson, Michael E. Scheurer, Dora Il’yasova, Daniel Lachance, et al. “Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.” Cancer Epidemiol Biomarkers Prev 25, no. 2 (February 2016): 282–90. https://doi.org/10.1158/1055-9965.EPI-15-0847.
       Full Text  Link to Item
    • Amirian, E Susan, Georgina N. Armstrong, Renke Zhou, Ching C. Lau, Elizabeth B. Claus, Jill S. Barnholtz-Sloan, Dora Il’yasova, et al. “The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium.” Am J Epidemiol 183, no. 2 (January 15, 2016): 85–91. https://doi.org/10.1093/aje/kwv235.
       Full Text  Link to Item
    • Fuemmeler, Bernard F., Chien-Ti Lee, Adelheid Soubry, Edwin S. Iversen, Zhiqing Huang, Amy P. Murtha, Joellen M. Schildkraut, Randy L. Jirtle, Susan K. Murphy, and Cathrine Hoyo. “DNA Methylation of Regulatory Regions of Imprinted Genes at Birth and Its Relation to Infant Temperament.” Genet Epigenet 8 (2016): 59–67. https://doi.org/10.4137/GEG.S40538.
       Full Text  Link to Item
    • Lee, Alice W., Claire Templeman, Douglas A. Stram, Jonathan Beesley, Jonathan Tyrer, Andrew Berchuck, Paul P. Pharoah, Georgia Chenevix-Trench, Celeste Leigh Pearce, and Celeste Leigh Ovarian Cancer Association Consortium. “Evidence of a genetic link between endometriosis and ovarian cancer.” Fertil Steril 105, no. 1 (January 2016): 35-43.e1-10. https://doi.org/10.1016/j.fertnstert.2015.09.023.
       Full Text  Link to Item
    • Scarbrough, Peter M., Rachel Palmieri Weber, Edwin S. Iversen, Yonathan Brhane, Christopher I. Amos, Peter Kraft, Rayjean J. Hung, et al. “A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.” Cancer Epidemiol Biomarkers Prev 25, no. 1 (January 2016): 193–200. https://doi.org/10.1158/1055-9965.EPI-15-0649.
       Full Text  Link to Item
    • Bolton, K. L., J. Tyrer, H. Song, S. J. Ramus, M. Notaridou, C. Jones, T. Sher, et al. “Erratum: Common variants at 19p13 are associated with susceptibility to ovarian cancer (Nature Genetics (2010) 42 (880-884)).” Nature Genetics 48, no. 1 (December 29, 2015): 101. https://doi.org/10.1038/ng0116-101b.
       Full Text
    • Seibold, Petra, Peter Schmezer, Sabine Behrens, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, Dieter Flesch-Janys, et al. “A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.” Bmc Cancer 15 (December 16, 2015): 978. https://doi.org/10.1186/s12885-015-1957-7.
       Full Text  Link to Item
    • Johnatty, Sharon E., Jonathan P. Tyrer, Siddhartha Kar, Jonathan Beesley, Yi Lu, Bo Gao, Peter A. Fasching, et al. “Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.” Clin Cancer Res 21, no. 23 (December 1, 2015): 5264–76. https://doi.org/10.1158/1078-0432.CCR-15-0632.
       Full Text  Link to Item
    • Amankwah, Ernest K., Hui-Yi Lin, Jonathan P. Tyrer, Kate Lawrenson, Joe Dennis, Ganna Chornokur, Katja K. H. Aben, et al. “Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.” Genet Epidemiol 39, no. 8 (December 2015): 689–97. https://doi.org/10.1002/gepi.21921.
       Full Text  Link to Item
    • Hung, Rayjean J., Cornelia M. Ulrich, Ellen L. Goode, Yonathan Brhane, Kenneth Muir, Andrew T. Chan, Loic Le Marchand, et al. “Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.” J Natl Cancer Inst 107, no. 11 (November 2015). https://doi.org/10.1093/jnci/djv246.
       Full Text  Link to Item
    • Lawrenson, Kate, Edwin S. Iversen, Jonathan Tyrer, Rachel Palmieri Weber, Patrick Concannon, Dennis J. Hazelett, Qiyuan Li, et al. “Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.” Carcinogenesis 36, no. 11 (November 2015): 1341–53. https://doi.org/10.1093/carcin/bgv138.
       Full Text  Link to Item
    • Richards, Edward J., Jennifer Permuth-Wey, Yajuan Li, Y Ann Chen, Domenico Coppola, Brett M. Reid, Hui-Yi Lin, et al. “A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.” Oncotarget 6, no. 33 (October 27, 2015): 34745–57. https://doi.org/10.18632/oncotarget.5784.
       Full Text  Link to Item
    • Lu, Yi, Gabriel Cuellar-Partida, Jodie N. Painter, Dale R. Nyholt, Dale R. Australian Ovarian Cancer Study, Dale R. International Endogene Consortium (IEC), Andrew P. Morris, et al. “Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.” Hum Mol Genet 24, no. 20 (October 15, 2015): 5955–64. https://doi.org/10.1093/hmg/ddv306.
       Full Text  Link to Item
    • Kar, Siddhartha P., Jonathan P. Tyrer, Qiyuan Li, Kate Lawrenson, Katja K. H. Aben, Hoda Anton-Culver, Natalia Antonenkova, et al. “Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.” Cancer Epidemiol Biomarkers Prev 24, no. 10 (October 2015): 1574–84. https://doi.org/10.1158/1055-9965.EPI-14-1270.
       Full Text  Link to Item
    • Lawrenson, Kate, Qiyuan Li, Siddhartha Kar, Ji-Heui Seo, Jonathan Tyrer, Tassja J. Spindler, Janet Lee, et al. “Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.” Nat Commun 6 (September 22, 2015): 8234. https://doi.org/10.1038/ncomms9234.
       Full Text  Link to Item
    • Nagle, C. M., S. C. Dixon, A. Jensen, S. K. Kjaer, F. Modugno, A. deFazio, S. Fereday, et al. “Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.” British Journal of Cancer 113, no. 5 (September 2015): 817–26. https://doi.org/10.1038/bjc.2015.245.
       Full Text
    • Kelemen, Linda E., Kate Lawrenson, Jonathan Tyrer, Qiyuan Li, Janet M. Lee, Ji-Heui Seo, Catherine M. Phelan, et al. “Genome-wide significant risk associations for mucinous ovarian carcinoma.” Nat Genet 47, no. 8 (August 2015): 888–97. https://doi.org/10.1038/ng.3336.
       Full Text  Link to Item
    • Vidal, Adriana C., Viktoriya Semenova, Thomas Darrah, Avner Vengosh, Zhiqing Huang, Katherine King, Monica D. Nye, et al. “Maternal cadmium, iron and zinc levels, DNA methylation and birth weight.” Bmc Pharmacol Toxicol 16 (July 15, 2015): 20. https://doi.org/10.1186/s40360-015-0020-2.
       Full Text  Link to Item
    • Coetzee, Simon G., Howard C. Shen, Dennis J. Hazelett, Kate Lawrenson, Karoline Kuchenbaecker, Jonathan Tyrer, Suhn K. Rhie, et al. “Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.” Hum Mol Genet 24, no. 13 (July 1, 2015): 3595–3607. https://doi.org/10.1093/hmg/ddv101.
       Full Text  Link to Item
    • Soubry, A., S. K. Murphy, F. Wang, Z. Huang, A. C. Vidal, B. F. Fuemmeler, J. Kurtzberg, et al. “Newborns of obese parents have altered DNA methylation patterns at imprinted genes.” International Journal of Obesity 39, no. 4 (April 9, 2015): 650–57. https://doi.org/10.1038/ijo.2013.193.
       Full Text
    • Pearce, Celeste Leigh, Daniel O. Stram, Roberta B. Ness, Douglas A. Stram, Lynda D. Roman, Claire Templeman, Alice W. Lee, et al. “Population distribution of lifetime risk of ovarian cancer in the United States.” Cancer Epidemiol Biomarkers Prev 24, no. 4 (April 2015): 671–76. https://doi.org/10.1158/1055-9965.EPI-14-1128.
       Full Text  Link to Item
    • Soubry, A., S. K. Murphy, F. Wang, Z. Huang, A. C. Vidal, B. F. Fuemmeler, J. Kurtzberg, et al. “Newborns of obese parents have altered DNA methylation patterns at imprinted genes.” Int J Obes (Lond) 39, no. 4 (April 2015): 650–57. https://doi.org/10.1038/ijo.2013.193.
       Full Text  Open Access Copy  Link to Item
    • Lee, Alice W., Jonathan P. Tyrer, Jennifer A. Doherty, Douglas A. Stram, Jolanta Kupryjanczyk, Agnieszka Dansonka-Mieszkowska, Joanna Plisiecka-Halasa, et al. “Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.” Gynecol Oncol 136, no. 3 (March 2015): 542–48. https://doi.org/10.1016/j.ygyno.2014.12.017.
       Full Text  Link to Item
    • Jalali, Ali, E Susan Amirian, Matthew N. Bainbridge, Georgina N. Armstrong, Yanhong Liu, Spyros Tsavachidis, Shalini N. Jhangiani, et al. “Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium.” Sci Rep 5 (February 5, 2015): 8278. https://doi.org/10.1038/srep08278.
       Full Text  Link to Item
    • Kuchenbaecker, Karoline B., Susan J. Ramus, Jonathan Tyrer, Andrew Lee, Howard C. Shen, Jonathan Beesley, Kate Lawrenson, et al. “Identification of six new susceptibility loci for invasive epithelial ovarian cancer.” Nat Genet 47, no. 2 (February 2015): 164–71. https://doi.org/10.1038/ng.3185.
       Full Text  Link to Item
    • Bainbridge, Matthew N., Georgina N. Armstrong, M Monica Gramatges, Alison A. Bertuch, Shalini N. Jhangiani, Harsha Doddapaneni, Lora Lewis, et al. “Germline mutations in shelterin complex genes are associated with familial glioma.” J Natl Cancer Inst 107, no. 1 (January 2015): 384. https://doi.org/10.1093/jnci/dju384.
       Full Text  Link to Item
    • Chornokur, Ganna, Hui-Yi Lin, Jonathan P. Tyrer, Kate Lawrenson, Joe Dennis, Ernest K. Amankwah, Xiaotao Qu, et al. “Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.” Plos One 10, no. 6 (2015): e0128106. https://doi.org/10.1371/journal.pone.0128106.
       Full Text  Link to Item
    • Claus, Elizabeth B., Kyle M. Walsh, John K. Wiencke, Annette M. Molinaro, Joseph L. Wiemels, Joellen M. Schildkraut, Melissa L. Bondy, Mitchel Berger, Robert Jenkins, and Margaret Wrensch. “Survival and low-grade glioma: the emergence of genetic information.” Neurosurg Focus 38, no. 1 (January 2015): E6. https://doi.org/10.3171/2014.10.FOCUS12367.
       Full Text  Link to Item
    • Segev, Y., S. Zhang, M. R. Akbari, P. Sun, T. A. Sellers, J. McLaughlin, H. A. Risch, et al. “Survival in women with ovarian cancer with and without microsatellite instability.” Eur J Gynaecol Oncol 36, no. 6 (2015): 681–84.
       Link to Item
    • Andersson, Ulrika, Carl Wibom, Kristina Cederquist, Steina Aradottir, Ake Borg, Georgina N. Armstrong, Sanjay Shete, et al. “Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.” Neuro Oncol 16, no. 10 (October 2014): 1333–40. https://doi.org/10.1093/neuonc/nou052.
       Full Text  Link to Item
    • Kelemen, Linda E., Kathryn L. Terry, Marc T. Goodman, Penelope M. Webb, Elisa V. Bandera, Valerie McGuire, Mary Anne Rossing, et al. “Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.” Mol Nutr Food Res 58, no. 10 (October 2014): 2023–35. https://doi.org/10.1002/mnfr.201400068.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michelle L. Cote, Ellen Funkhouser, et al. “A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES).” Bmc Cancer 14 (September 22, 2014): 688. https://doi.org/10.1186/1471-2407-14-688.
       Full Text  Link to Item
    • Brenner, Darren R., Dominique Scherer, Kenneth Muir, Joellen Schildkraut, Paolo Boffetta, Margaret R. Spitz, Loic Le Marchand, et al. “A review of the application of inflammatory biomarkers in epidemiologic cancer research.” Cancer Epidemiol Biomarkers Prev 23, no. 9 (September 2014): 1729–51. https://doi.org/10.1158/1055-9965.EPI-14-0064.
       Full Text  Link to Item
    • Hoyo, Cathrine, Anne Kjersti Daltveit, Edwin Iversen, Sara E. Benjamin-Neelon, Bernard Fuemmeler, Joellen Schildkraut, Amy P. Murtha, et al. “Erythrocyte folate concentrations, CpG methylation at genomically imprinted domains, and birth weight in a multiethnic newborn cohort.” Epigenetics 9, no. 8 (August 2014): 1120–30. https://doi.org/10.4161/epi.29332.
       Full Text  Link to Item
    • Block, Matthew S., Bridget Charbonneau, Robert A. Vierkant, Zachary Fogarty, William R. Bamlet, Paul D. P. Pharoah, Paul D. P. Georgia Chenevix-Trench, et al. “Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.” Cancer Epidemiol Biomarkers Prev 23, no. 7 (July 2014): 1421–27. https://doi.org/10.1158/1055-9965.EPI-13-0962.
       Full Text  Link to Item
    • Hedditch, Ellen L., Bo Gao, Amanda J. Russell, Yi Lu, Catherine Emmanuel, Jonathan Beesley, Sharon E. Johnatty, et al. “ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.” J Natl Cancer Inst 106, no. 7 (July 2014). https://doi.org/10.1093/jnci/dju149.
       Full Text  Link to Item
    • Earp, Madalene A., Linda E. Kelemen, Anthony M. Magliocco, Kenneth D. Swenerton, Georgia Chenevix-Trench, Georgia Australian Cancer Study, Georgia Australian Ovarian Cancer Study Group, et al. “Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.” Hum Genet 133, no. 5 (May 2014): 481–97. https://doi.org/10.1007/s00439-013-1383-3.
       Full Text  Link to Item
    • Segev, Yakir, Tuya Pal, Barry Rosen, John R. McLaughlin, Thomas A. Sellers, Harvey A. Risch, Shiyu Zhang, Ping Sun, Steven A. Narod, and Joellen Schildkraut. “Risk factors for ovarian cancers with and without microsatellite instability.” Int J Gynecol Cancer 24, no. 4 (May 2014): 664–69. https://doi.org/10.1097/IGC.0000000000000134.
       Full Text  Link to Item
    • Charbonneau, Bridget, Kirsten B. Moysich, Kimberly R. Kalli, Ann L. Oberg, Robert A. Vierkant, Zachary C. Fogarty, Matthew S. Block, et al. “Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.” Cancer Immunol Res 2, no. 4 (April 2014): 332–40. https://doi.org/10.1158/2326-6066.CIR-13-0136.
       Full Text  Link to Item
    • Lee, Ji-Hyun, Deborah Cragun, Zachary Thompson, Domenico Coppola, Santo V. Nicosia, Mohammad Akbari, Shiyu Zhang, et al. “Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer.” Genet Test Mol Biomarkers 18, no. 4 (April 2014): 229–35. https://doi.org/10.1089/gtmb.2013.0393.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Lisa Calvocoressi, Frances Wang, Margaret Wrensch, Melissa L. Bondy, Joseph L. Wiemels, and Elizabeth B. Claus. “Endogenous and exogenous hormone exposure and the risk of meningioma in men.” J Neurosurg 120, no. 4 (April 2014): 820–26. https://doi.org/10.3171/2013.12.JNS131170.
       Full Text  Link to Item
    • Charbonneau, Bridget, Matthew S. Block, William R. Bamlet, Robert A. Vierkant, Kimberly R. Kalli, Zachary Fogarty, David N. Rider, et al. “Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.” Cancer Res 74, no. 3 (February 1, 2014): 852–61. https://doi.org/10.1158/0008-5472.CAN-13-1051.
       Full Text  Link to Item
    • Trabert, Britton, Roberta B. Ness, Wei-Hsuan Lo-Ciganic, Megan A. Murphy, Ellen L. Goode, Elizabeth M. Poole, Louise A. Brinton, et al. “Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.” J Natl Cancer Inst 106, no. 2 (February 2014): djt431. https://doi.org/10.1093/jnci/djt431.
       Full Text  Link to Item
    • Larson, Nicholas B., Gregory D. Jenkins, Melissa C. Larson, Robert A. Vierkant, Thomas A. Sellers, Catherine M. Phelan, Joellen M. Schildkraut, et al. “Kernel canonical correlation analysis for assessing gene-gene interactions and application to ovarian cancer.” Eur J Hum Genet 22, no. 1 (January 2014): 126–31. https://doi.org/10.1038/ejhg.2013.69.
       Full Text  Link to Item
    • Vidal, Adriana C., Sara E. Benjamin Neelon, Ying Liu, Abbas M. Tuli, Bernard F. Fuemmeler, Cathrine Hoyo, Amy P. Murtha, et al. “Maternal stress, preterm birth, and DNA methylation at imprint regulatory sequences in humans.” Genet Epigenet 6 (2014): 37–44. https://doi.org/10.4137/GEG.S18067.
       Full Text  Link to Item
    • Pooley, Karen A., Stig E. Bojesen, Maren Weischer, Sune F. Nielsen, Deborah Thompson, Ali Amin Al Olama, Kyriaki Michailidou, et al. “A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk.” Hum Mol Genet 22, no. 24 (December 15, 2013): 5056–64. https://doi.org/10.1093/hmg/ddt355.
       Full Text  Link to Item
    • Vidal, Adriana C., Cocoa Tucker, Joellen M. Schildkraut, Ricardo M. Richardson, Megan McPhail, Stephen J. Freedland, Cathrine Hoyo, and Delores J. Grant. “Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.” Bmc Cancer 13 (November 22, 2013): 556. https://doi.org/10.1186/1471-2407-13-556.
       Full Text  Open Access Copy  Link to Item
    • Schildkraut, Joellen M., Edwin S. Iversen, Lucy Akushevich, Regina Whitaker, Rex C. Bentley, Andrew Berchuck, and Jeffrey R. Marks. “Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors.” Cancer Epidemiol Biomarkers Prev 22, no. 10 (October 2013): 1709–21. https://doi.org/10.1158/1055-9965.EPI-13-0192.
       Full Text  Link to Item
    • Wentzensen, N., B. Trabert, and J. Schildkraut. “Ovarian Cancer,” August 29, 2013, 1135–45. https://doi.org/10.1016/B978-0-12-384978-6.00075-3.
       Full Text
    • Terry, Kathryn L., Stalo Karageorgi, Yurii B. Shvetsov, Melissa A. Merritt, Galina Lurie, Pamela J. Thompson, Michael E. Carney, et al. “Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.” Cancer Prevention Research (Philadelphia, Pa.) 6, no. 8 (August 2013): 811–21. https://doi.org/10.1158/1940-6207.capr-13-0037.
       Full Text
    • Segev, Yakir, Tuya Pal, Barry Rosen, John R. McLaughlin, Thomas A. Sellers, Harvey A. Risch, Shiyu Zhang, Sun Ping, Steven A. Narod, and Joellen Schildkraut. “Risk factors for ovarian cancers with and without microsatellite instability.” Int J Gynecol Cancer 23, no. 6 (July 2013): 1010–15. https://doi.org/10.1097/IGC.0b013e31829a5527.
       Full Text  Link to Item
    • Vidal, A. C., S. K. Murphy, A. P. Murtha, J. M. Schildkraut, A. Soubry, Z. Huang, S. E. B. Neelon, et al. “Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring.” International Journal of Obesity (2005) 37, no. 7 (July 2013): 907–13. https://doi.org/10.1038/ijo.2013.47.
       Full Text
    • Faber, Mette T., Susanne K. Kjær, Christian Dehlendorff, Jenny Chang-Claude, Klaus K. Andersen, Estrid Høgdall, Penelope M. Webb, et al. “Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.” Cancer Causes Control 24, no. 5 (May 2013): 989–1004. https://doi.org/10.1007/s10552-013-0174-4.
       Full Text  Link to Item
    • Pearce, Celeste Leigh, Mary Anne Rossing, Alice W. Lee, Roberta B. Ness, Penelope M. Webb, Penelope M. for Australian Cancer Study (Ovarian Cancer), Penelope M. Australian Ovarian Cancer Study Group, et al. “Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.” Cancer Epidemiol Biomarkers Prev 22, no. 5 (May 2013): 880–90. https://doi.org/10.1158/1055-9965.EPI-12-1030-T.
       Full Text  Link to Item
    • White, Kristin L., Robert A. Vierkant, Zachary C. Fogarty, Bridget Charbonneau, Matthew S. Block, Paul D. P. Pharoah, Georgia Chenevix-Trench, et al. “Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.” Cancer Epidemiol Biomarkers Prev 22, no. 5 (May 2013): 987–92. https://doi.org/10.1158/1055-9965.EPI-13-0028.
       Full Text  Link to Item
    • Bojesen, Stig E., Karen A. Pooley, Sharon E. Johnatty, Jonathan Beesley, Kyriaki Michailidou, Jonathan P. Tyrer, Stacey L. Edwards, et al. “Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.” Nat Genet 45, no. 4 (April 2013): 371-384e2. https://doi.org/10.1038/ng.2566.
       Full Text  Link to Item
    • Chornokur, Ganna, Ernest K. Amankwah, Joellen M. Schildkraut, and Catherine M. Phelan. “Global ovarian cancer health disparities.” Gynecol Oncol 129, no. 1 (April 2013): 258–64. https://doi.org/10.1016/j.ygyno.2012.12.016.
       Full Text  Link to Item
    • Grant, Delores J., Cathrine Hoyo, Lucy Akushevich, Edwin S. Iversen, Regina Whitaker, Jeffrey Marks, Andrew Berchuck, and Joellen M. Schildkraut. “Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.” Gynecol Oncol 129, no. 1 (April 2013): 173–78. https://doi.org/10.1016/j.ygyno.2012.12.027.
       Full Text  Link to Item
    • Olsen, Catherine M., Christina M. Nagle, David C. Whiteman, Roberta Ness, Celeste Leigh Pearce, Malcolm C. Pike, Mary Anne Rossing, et al. “Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.” Endocr Relat Cancer 20, no. 2 (April 2013): 251–62. https://doi.org/10.1530/ERC-12-0395.
       Full Text  Link to Item
    • Sadetzki, Siegal, Revital Bruchim, Bernice Oberman, Georgina N. Armstrong, Ching C. Lau, Elizabeth B. Claus, Jill S. Barnholtz-Sloan, et al. “Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.” Eur J Cancer 49, no. 6 (April 2013): 1335–45. https://doi.org/10.1016/j.ejca.2012.11.009.
       Full Text  Link to Item
    • Sfakianos, Gregory P., Edwin S. Iversen, Regina Whitaker, Liudmila Akushevich, Joellen M. Schildkraut, Susan K. Murphy, Jeffrey R. Marks, and Andrew Berchuck. “Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues.” Gynecol Oncol 129, no. 1 (April 2013): 159–64. https://doi.org/10.1016/j.ygyno.2012.12.030.
       Full Text  Link to Item
    • Sieh, Weiva, Shannon Salvador, Valerie McGuire, Rachel Palmieri Weber, Kathryn L. Terry, Mary Anne Rossing, Harvey Risch, et al. “Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.” Int J Epidemiol 42, no. 2 (April 2013): 579–89. https://doi.org/10.1093/ije/dyt042.
       Full Text  Link to Item
    • Pharoah, Paul D. P., Ya-Yu Tsai, Susan J. Ramus, Catherine M. Phelan, Ellen L. Goode, Kate Lawrenson, Melissa Buckley, et al. “GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.” Nat Genet 45, no. 4 (April 2013): 362-370e2. https://doi.org/10.1038/ng.2564.
       Full Text  Link to Item
    • Claus, Elizabeth B., Lisa Calvocoressi, Melissa L. Bondy, Margaret Wrensch, Joseph L. Wiemels, and Joellen M. Schildkraut. “Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females.” J Neurosurg 118, no. 3 (March 2013): 649–56. https://doi.org/10.3171/2012.9.JNS12811.
       Full Text  Link to Item
    • Soubry, Adelheid, Joellen M. Schildkraut, Amy Murtha, Frances Wang, Zhiqing Huang, Autumn Bernal, Joanne Kurtzberg, Randy L. Jirtle, Susan K. Murphy, and Cathrine Hoyo. “Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort.” Bmc Medicine 11 (February 6, 2013): 29. https://doi.org/10.1186/1741-7015-11-29.
       Full Text
    • Kelemen, Linda E., Elisa V. Bandera, Kathryn L. Terry, Mary Anne Rossing, Louise A. Brinton, Jennifer A. Doherty, Roberta B. Ness, et al. “Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.” Bmc Cancer 13 (January 22, 2013): 28. https://doi.org/10.1186/1471-2407-13-28.
       Full Text  Link to Item
    • Faber, M. T., S. K. Kjær, C. Dehlendorff, J. Chang-Claude, K. K. Andersen, E. Høgdall, P. M. Webb, et al. “Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.” Cancer Causes and Control, 2013, 1–16.
    • Goode, Ellen L., Melissa DeRycke, Kimberly R. Kalli, Ann L. Oberg, Julie M. Cunningham, Matthew J. Maurer, Brooke L. Fridley, et al. “Inherited variants in regulatory T cell genes and outcome of ovarian cancer.” Plos One 8, no. 1 (2013): e53903. https://doi.org/10.1371/journal.pone.0053903.
       Full Text  Link to Item
    • Permuth-Wey, Jennifer, Kate Lawrenson, Howard C. Shen, Aneliya Velkova, Jonathan P. Tyrer, Zhihua Chen, Hui-Yi Lin, et al. “Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.” Nat Commun 4 (2013): 1627. https://doi.org/10.1038/ncomms2613.
       Full Text  Link to Item
    • Shen, Hui, Brooke L. Fridley, Honglin Song, Kate Lawrenson, Julie M. Cunningham, Susan J. Ramus, Mine S. Cicek, et al. “Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.” Nat Commun 4 (2013): 1628. https://doi.org/10.1038/ncomms2629.
       Full Text  Link to Item
    • Vidal, A. C., S. K. Murphy, A. P. Murtha, J. M. Schildkraut, A. Soubry, Z. Huang, S. E. B. Neelon, et al. “Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring.” International Journal of Obesity 37, no. 7 (2013): 907–13. https://doi.org/10.1038/ijo.2013.47.
       Full Text
    • Vidal, Adriana C., Amy P. Murtha, Susan K. Murphy, Kimberly Fortner, Francine Overcash, Nikki Henry, Joellen M. Schildkraut, et al. “Maternal BMI, IGF-I Levels, and Birth Weight in African American and White Infants.” Int J Pediatr 2013 (2013): 191472. https://doi.org/10.1155/2013/191472.
       Full Text  Link to Item
    • Vidal, Adriana C., Francine Overcash, Susan K. Murphy, Amy P. Murtha, Joellen M. Schildkraut, Michele R. Forman, Wendy Demark-Wahnefried, et al. “Associations between birth and one year anthropometric measurements and IGF2 and IGF2R genetic variants in African American and Caucasian American infants.” J Pediatr Genet 2, no. 3 (2013). https://doi.org/10.3233/PGE-13064.
       Full Text  Link to Item
    • Wiemels, Joseph L., Paige M. Bracci, Margaret Wrensch, Joellen Schildkraut, Melissa Bondy, Jon Pfefferle, Mi Zhou, Jennette Sison, Lisa Calvocoressi, and Elizabeth B. Claus. “Assessment of autoantibodies to meningioma in a population-based study.” Am J Epidemiol 177, no. 1 (January 1, 2013): 75–83. https://doi.org/10.1093/aje/kws221.
       Full Text  Link to Item
    • Grant, Delores J., Cathrine Hoyo, Shannon D. Oliver, Leah Gerber, Katie Shuler, Elizabeth Calloway, Alexis R. Gaines, et al. “Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.” Genetic Testing and Molecular Biomarkers 17, no. 1 (January 2013): 3–9. https://doi.org/10.1089/gtmb.2012.0161.
       Full Text
    • Sun, Xiangqing, Jaime Vengoechea, Robert Elston, Yanwen Chen, Christopher I. Amos, Georgina Armstrong, Jonine L. Bernstein, et al. “A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma.” Cancer Epidemiol Biomarkers Prev 21, no. 12 (December 2012): 2242–51. https://doi.org/10.1158/1055-9965.EPI-12-0703.
       Full Text  Link to Item
    • Pal, T., M. R. Akbari, P. Sun, J. -. H. Lee, J. Fulp, Z. Thompson, D. Coppola, et al. “Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer.” Br J Cancer 107, no. 10 (November 6, 2012): 1783–90. https://doi.org/10.1038/bjc.2012.452.
       Full Text  Link to Item
    • Coppola, Domenico, Santo V. Nicosia, Andrea Doty, Thomas A. Sellers, Ji-Hyun Lee, Jimmy Fulp, Zachary Thompson, et al. “Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer.” Anticancer Res 32, no. 11 (November 2012): 4963–69.
       Link to Item
    • Poole, Elizabeth M., Margaret A. Gates, Brigit A. High, Stephen J. Chanock, Daniel W. Cramer, Julie M. Cunningham, Brooke L. Fridley, et al. “ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.” Cancer Causes Control 23, no. 11 (November 2012): 1805–10. https://doi.org/10.1007/s10552-012-0059-y.
       Full Text  Link to Item
    • Claus, Elizabeth B., Lisa Calvocoressi, Melissa L. Bondy, Joellen M. Schildkraut, Joseph L. Wiemels, and Margaret Wrensch. “Dental x-rays and risk of meningioma.” Cancer 118, no. 18 (September 15, 2012): 4530–37. https://doi.org/10.1002/cncr.26625.
       Full Text  Link to Item
    • Liu, Yanhong, Beatrice S. Melin, Preetha Rajaraman, Zhaoming Wang, Martha Linet, Sanjay Shete, Christopher I. Amos, et al. “Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma.” Hum Genet 131, no. 9 (September 2012): 1507–17. https://doi.org/10.1007/s00439-012-1187-x.
       Full Text  Link to Item
    • Liu, Ying, Susan K. Murphy, Amy P. Murtha, Bernard F. Fuemmeler, Joellen Schildkraut, Zhiqing Huang, Francine Overcash, et al. “Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements.” Epigenetics 7, no. 7 (July 2012): 735–46. https://doi.org/10.4161/epi.20734.
       Full Text  Link to Item
    • Perkins, Ellen, Susan K. Murphy, Amy P. Murtha, Joellen Schildkraut, Randy L. Jirtle, Wendy Demark-Wahnefried, Michele R. Forman, et al. “Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children.” The Journal of Pediatrics 161, no. 1 (July 2012): 31–39. https://doi.org/10.1016/j.jpeds.2012.01.015.
       Full Text
    • Claus, Elizabeth B., Kyle M. Walsh, Lisa Calvocoressi, Melissa L. Bondy, Joellen M. Schildkraut, Margaret Wrensch, and Joseph L. Wiemels. “Cigarette smoking and risk of meningioma: the effect of gender.” Cancer Epidemiol Biomarkers Prev 21, no. 6 (June 2012): 943–50. https://doi.org/10.1158/1055-9965.EPI-11-1059.
       Full Text  Link to Item
    • Finkelman, Brian S., Wendy S. Rubinstein, Sue Friedman, Tara M. Friebel, Shera Dubitsky, Niecee Singer Schonberger, Rochelle Shoretz, et al. “Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.” J Clin Oncol 30, no. 12 (April 20, 2012): 1321–28. https://doi.org/10.1200/JCO.2011.37.8133.
       Full Text  Link to Item
    • Hoyo, Cathrine, Kimberly Fortner, Amy P. Murtha, Joellen M. Schildkraut, Adelheid Soubry, Wendy Demark-Wahnefried, Randy L. Jirtle, et al. “Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight.” Cancer Causes Control 23, no. 4 (April 2012): 635–45. https://doi.org/10.1007/s10552-012-9932-y.
       Full Text  Link to Item
    • Pearce, Celeste Leigh, Claire Templeman, Mary Anne Rossing, Alice Lee, Aimee M. Near, Penelope M. Webb, Christina M. Nagle, et al. “Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.” Lancet Oncol 13, no. 4 (April 2012): 385–94. https://doi.org/10.1016/S1470-2045(11)70404-1.
       Full Text  Link to Item
    • Fridley, Brooke L., Gregory D. Jenkins, Ya-Yu Tsai, Honglin Song, Kelly L. Bolton, David Fenstermacher, Jonathan Tyrer, et al. “Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.” Cancer Epidemiol Biomarkers Prev 21, no. 3 (March 2012): 529–36. https://doi.org/10.1158/1055-9965.EPI-11-0741.
       Full Text  Link to Item
    • Stevens, Kristen N., Linda E. Kelemen, Xianshu Wang, Brooke L. Fridley, Robert A. Vierkant, Zachary Fredericksen, Sebastian M. Armasu, et al. “Common variation in Nemo-like kinase is associated with risk of ovarian cancer.” Cancer Epidemiol Biomarkers Prev 21, no. 3 (March 2012): 523–28. https://doi.org/10.1158/1055-9965.EPI-11-0797.
       Full Text  Link to Item
    • White, Kristin L., Joellen M. Schildkraut, Rachel T. Palmieri, Edwin S. Iversen, Andrew Berchuck, Robert A. Vierkant, David N. Rider, et al. “Ovarian cancer risk associated with inherited inflammation-related variants.” Cancer Res 72, no. 5 (March 1, 2012): 1064–69. https://doi.org/10.1158/0008-5472.CAN-11-3512.
       Full Text  Link to Item
    • Murphy, Susan K., Abayomi Adigun, Zhiqing Huang, Francine Overcash, Frances Wang, Randy L. Jirtle, Joellen M. Schildkraut, Amy P. Murtha, Edwin S. Iversen, and Cathrine Hoyo. “Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke.” Gene 494, no. 1 (February 15, 2012): 36–43. https://doi.org/10.1016/j.gene.2011.11.062.
       Full Text  Link to Item
    • Fridley, Brooke L., Prabhakar Chalise, Ya-Yu Tsai, Zhifu Sun, Robert A. Vierkant, Melissa C. Larson, Julie M. Cunningham, et al. “Germline copy number variation and ovarian cancer survival.” Front Genet 3 (2012): 142. https://doi.org/10.3389/fgene.2012.00142.
       Full Text  Link to Item
    • Hoyo, Cathrine, Susan K. Murphy, Joellen M. Schildkraut, Adriana C. Vidal, David Skaar, Robert C. Millikan, Joseph Galanko, Robert S. Sandler, Randy Jirtle, and Temitope Keku. “IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites.” Dis Markers 32, no. 2 (2012): 133–41. https://doi.org/10.3233/DMA-2011-0865.
       Full Text  Link to Item
    • Kelemen, Linda E., Qinggang Wang, Irina Dinu, Robert A. Vierkant, Ya-Yu Tsai, Julie M. Cunningham, Catherine M. Phelan, et al. “Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma.” Front Genet 3 (2012): 33. https://doi.org/10.3389/fgene.2012.00033.
       Full Text  Link to Item
    • Lowery, William J., Joellen M. Schildkraut, Liudmila Akushevich, Rex Bentley, Jeffrey R. Marks, David Huntsman, and Andrew Berchuck. “Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.” Int J Gynecol Cancer 22, no. 1 (January 2012): 9–14. https://doi.org/10.1097/IGC.0b013e318231f140.
       Full Text  Link to Item
    • Raska, Paola, Edwin Iversen, Ann Chen, Zhihua Chen, Brooke L. Fridley, Jennifer Permuth-Wey, Ya-Yu Tsai, et al. “European American stratification in ovarian cancer case control data: the utility of genome-wide data for inferring ancestry.” Plos One 7, no. 5 (2012): e35235. https://doi.org/10.1371/journal.pone.0035235.
       Full Text  Link to Item
    • Shete, Sanjay, Ching C. Lau, Richard S. Houlston, Elizabeth B. Claus, Jill Barnholtz-Sloan, Rose Lai, Dora Il’yasova, et al. “Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.” Cancer Res 71, no. 24 (December 15, 2011): 7568–75. https://doi.org/10.1158/0008-5472.CAN-11-0013.
       Full Text  Link to Item
    • Claus, Elizabeth B., Lisa Calvocoressi, Melissa L. Bondy, Joellen M. Schildkraut, Joseph L. Wiemels, and Margaret Wrensch. “Family and personal medical history and risk of meningioma.” J Neurosurg 115, no. 6 (December 2011): 1072–77. https://doi.org/10.3171/2011.6.JNS11129.
       Full Text  Link to Item
    • Moorman, Patricia G., Evan R. Myers, Joellen M. Schildkraut, Edwin S. Iversen, Frances Wang, and Nicolette Warren. “Effect of hysterectomy with ovarian preservation on ovarian function.” Obstet Gynecol 118, no. 6 (December 2011): 1271–79. https://doi.org/10.1097/AOG.0b013e318236fd12.
       Full Text  Link to Item
    • Gaudet, Mia M., Michael F. Press, Robert W. Haile, Charles F. Lynch, Sally L. Glaser, Joellen Schildkraut, Marilie D. Gammon, W. Douglas Thompson, and Jonine L. Bernstein. “Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.” Breast Cancer Res Treat 130, no. 2 (November 2011): 587–97. https://doi.org/10.1007/s10549-011-1616-x.
       Full Text  Link to Item
    • Il’yasova, Dora, Sharareh Siamakpour-Reihani, Igor Akushevich, Lucy Akushevich, Neil Spector, and Joellen Schildkraut. “What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?” Breast Cancer Res Treat 130, no. 2 (November 2011): 691–97. https://doi.org/10.1007/s10549-011-1719-4.
       Full Text  Link to Item
    • Soubry, A., Sk Murphy, Z. Huang, A. Murtha, Jm Schildkraut, Rl Jirtle, F. Wang, et al. “The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring.” Clin Epigenetics 3 (October 26, 2011): 2. https://doi.org/10.1186/1868-7083-3-2.
       Full Text  Link to Item
    • Wiemels, Joseph L., Margaret Wrensch, Jennette D. Sison, Mi Zhou, Melissa Bondy, Lisa Calvocoressi, Peter M. Black, Herbert Yu, Joellen M. Schildkraut, and Elizabeth B. Claus. “Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls.” Int J Cancer 129, no. 8 (October 15, 2011): 1932–39. https://doi.org/10.1002/ijc.25858.
       Full Text  Link to Item
    • Neklason, Deborah W., Michelle W. Done, Nykole R. Sargent, Ann G. Schwartz, Hoda Anton-Culver, Constance A. Griffin, Dennis J. Ahnen, et al. “Activating mutation in MET oncogene in familial colorectal cancer.” Bmc Cancer 11 (October 4, 2011): 424. https://doi.org/10.1186/1471-2407-11-424.
       Full Text  Link to Item
    • Goode, Ellen L., Georgia Chenevix-Trench, Lynn C. Hartmann, Brooke L. Fridley, Kimberly R. Kalli, Robert A. Vierkant, Melissa C. Larson, et al. “Assessment of hepatocyte growth factor in ovarian cancer mortality.” Cancer Epidemiol Biomarkers Prev 20, no. 8 (August 2011): 1638–48. https://doi.org/10.1158/1055-9965.EPI-11-0455.
       Full Text  Link to Item
    • Permuth-Wey, Jennifer, Zhihua Chen, Ya-Yu Tsai, Hui-Yi Lin, Y Ann Chen, Jill Barnholtz-Sloan, Michael J. Birrer, et al. “MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.” Cancer Epidemiol Biomarkers Prev 20, no. 8 (August 2011): 1793–97. https://doi.org/10.1158/1055-9965.EPI-11-0397.
       Full Text  Link to Item
    • Hoyo, Cathrine, Amy P. Murtha, Joellen M. Schildkraut, Randy L. Jirtle, Wendy Demark-Wahnefried, Michele R. Forman, Edwin S. Iversen, et al. “Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy.” Epigenetics 6, no. 7 (July 2011): 928–36. https://doi.org/10.4161/epi.6.7.16263.
       Full Text  Link to Item
    • Moorman, Patricia G., Joellen M. Schildkraut, Evan R. Myers, and Frances Wang. “Reported symptoms before and one year after hysterectomy in African American and white women.” J Womens Health (Larchmt) 20, no. 7 (July 2011): 1035–42. https://doi.org/10.1089/jwh.2010.2543.
       Full Text  Link to Item
    • Pearce, Celeste Leigh, Jennifer A. Doherty, David J. Van Den Berg, Kirsten Moysich, Chris Hsu, Kara L. Cushing-Haugen, David V. Conti, et al. “Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.” Hum Mol Genet 20, no. 11 (June 1, 2011): 2263–72. https://doi.org/10.1093/hmg/ddr087.
       Full Text  Link to Item
    • Permuth-Wey, Jennifer, Donghwa Kim, Ya-Yu Tsai, Hui-Yi Lin, Y Ann Chen, Jill Barnholtz-Sloan, Michael J. Birrer, et al. “LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.” Cancer Res 71, no. 11 (June 1, 2011): 3896–3903. https://doi.org/10.1158/0008-5472.CAN-10-4167.
       Full Text  Link to Item
    • Permuth-Wey, Jennifer, Y Ann Chen, Ya-Yu Tsai, Zhihua Chen, Xiaotao Qu, Johnathan M. Lancaster, Heather Stockwell, et al. “Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.” Cancer Epidemiol Biomarkers Prev 20, no. 6 (June 2011): 1131–45. https://doi.org/10.1158/1055-9965.EPI-10-1224.
       Full Text  Link to Item
    • Pharoah, Paul D. P., Rachel T. Palmieri, Susan J. Ramus, Simon A. Gayther, Irene L. Andrulis, Hoda Anton-Culver, Natalia Antonenkova, et al. “The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.” Clin Cancer Res 17, no. 11 (June 1, 2011): 3742–50. https://doi.org/10.1158/1078-0432.CCR-10-3405.
       Full Text  Link to Item
    • Amankwah, Ernest K., Linda E. Kelemen, Qinggang Wang, Honglin Song, Georgia Chenevix-Trench, Georgia Australian Ovarian Cancer Study Group, Jonathan Beesley, et al. “Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.” Cancer Epidemiol Biomarkers Prev 20, no. 5 (May 2011): 1028–31. https://doi.org/10.1158/1055-9965.EPI-11-0053.
       Full Text  Link to Item
    • Goode, Ellen L., Kristin L. White, Robert A. Vierkant, Catherine M. Phelan, Julie M. Cunningham, Joellen M. Schildkraut, Andrew Berchuck, et al. “Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.” Mol Carcinog 50, no. 5 (May 2011): 397–402. https://doi.org/10.1002/mc.20714.
       Full Text  Link to Item
    • Notaridou, Maria, Lydia Quaye, Dimitra Dafou, Chris Jones, Honglin Song, Estrid Høgdall, Susanne K. Kjaer, et al. “Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.” Int J Cancer 128, no. 9 (May 1, 2011): 2063–74. https://doi.org/10.1002/ijc.25554.
       Full Text  Link to Item
    • Moorman, Patricia G., Lee W. Jones, Lucy Akushevich, and Joellen M. Schildkraut. “Recreational physical activity and ovarian cancer risk and survival.” Ann Epidemiol 21, no. 3 (March 2011): 178–87. https://doi.org/10.1016/j.annepidem.2010.10.014.
       Full Text  Link to Item
    • Schildkraut, Joellen M. “Endometrial cancer.” Gynecol Oncol 120, no. 2 (February 2011): 165–66. https://doi.org/10.1016/j.ygyno.2011.01.001.
       Full Text  Link to Item
    • Hoyo, Cathrine, Amy P. Murtha, Joellen M. Schildkraut, Michele R. Forman, Brian Calingaert, Wendy Demark-Wahnefried, Joanne Kurtzberg, Randy L. Jirtle, and Susan K. Murphy. “Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST).” Bmc Public Health 11, no. 1 (January 21, 2011): 46. https://doi.org/10.1186/1471-2458-11-46.
       Full Text  Link to Item
    • Amankwah, Ernest K., Qinggang Wang, Joellen M. Schildkraut, Ya-Yu Tsai, Susan J. Ramus, Brooke L. Fridley, Jonathan Beesley, et al. “Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.” Plos One 6, no. 5 (2011): e19642. https://doi.org/10.1371/journal.pone.0019642.
       Full Text  Link to Item
    • Lurie, Galina, Lynne R. Wilkens, Pamela J. Thompson, Yurii B. Shvetsov, Rayna K. Matsuno, Michael E. Carney, Rachel T. Palmieri, et al. “Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.” Plos One 6, no. 6 (2011): e20703. https://doi.org/10.1371/journal.pone.0020703.
       Full Text  Link to Item
    • Near, Aimee M., Anna H. Wu, Claire Templeman, David J. Van Den Berg, Jennifer A. Doherty, Mary Anne Rossing, Ellen L. Goode, et al. “Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.” Fertil Steril 95, no. 1 (January 2011): 40–45. https://doi.org/10.1016/j.fertnstert.2010.06.059.
       Full Text  Link to Item
    • Moorman, Patricia G., Edwin S. Iversen, P Kelly Marcom, Jeffrey R. Marks, Frances Wang, Frances Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Eunjung Lee, et al. “Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.” Breast Cancer Res Treat 124, no. 2 (November 2010): 441–51. https://doi.org/10.1007/s10549-010-0842-y.
       Full Text  Link to Item
    • Bolton, Kelly L., Jonathan Tyrer, Honglin Song, Susan J. Ramus, Maria Notaridou, Chris Jones, Tanya Sher, et al. “Common variants at 19p13 are associated with susceptibility to ovarian cancer.” Nat Genet 42, no. 10 (October 2010): 880–84. https://doi.org/10.1038/ng.666.
       Full Text  Link to Item
    • Goode, Ellen L., Georgia Chenevix-Trench, Honglin Song, Susan J. Ramus, Maria Notaridou, Kate Lawrenson, Martin Widschwendter, et al. “A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.” Nat Genet 42, no. 10 (October 2010): 874–79. https://doi.org/10.1038/ng.668.
       Full Text  Link to Item
    • Domchek, Susan M., Tara M. Friebel, Christian F. Singer, D Gareth Evans, Henry T. Lynch, Claudine Isaacs, Judy E. Garber, et al. “Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.” Jama 304, no. 9 (September 1, 2010): 967–75. https://doi.org/10.1001/jama.2010.1237.
       Full Text  Link to Item
    • Robertson, L. B., G. N. Armstrong, B. D. Olver, A. L. Lloyd, S. Shete, C. Lau, E. B. Claus, et al. “Erratum: Survey of familial glioma and role of germline p16 ^INK4A/p14^ARF and p53 mutation (Familial Cancer DOI: 10.1007/s10689-010-9346-5).” Familial Cancer 9, no. 3 (September 1, 2010): 423–24. https://doi.org/10.1007/s10689-010-9353-6.
       Full Text
    • Robertson, Lindsay B., Georgina N. Armstrong, Bianca D. Olver, Amy L. Lloyd, Sanjay Shete, Ching Lau, Elizabeth B. Claus, et al. “Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation.” Fam Cancer 9, no. 3 (September 2010): 413–21. https://doi.org/10.1007/s10689-010-9346-5.
       Full Text  Link to Item
    • Wilson, Melanie A., Edwin S. Iversen, Merlise A. Clyde, Scott C. Schmidler, and Joellen M. Schildkraut. “BAYESIAN MODEL SEARCH AND MULTILEVEL INFERENCE FOR SNP ASSOCIATION STUDIES.” Ann Appl Stat 4, no. 3 (September 1, 2010): 1342–64. https://doi.org/10.1214/09-aoas322.
       Full Text  Open Access Copy  Link to Item
    • Johnatty, Sharon E., Jonathan Beesley, Xiaoqing Chen, Stuart Macgregor, David L. Duffy, Amanda B. Spurdle, Anna deFazio, et al. “Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".” Plos Genet 6, no. 7 (July 8, 2010): e1001016. https://doi.org/10.1371/journal.pgen.1001016.
       Full Text  Link to Item
    • Grant, Delores J., Patricia G. Moorman, Lucy Akushevich, Rachel T. Palmieri, Rex C. Bentley, and Joellen M. Schildkraut. “Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.” Cancer Causes Control 21, no. 7 (July 2010): 991–98. https://doi.org/10.1007/s10552-010-9525-6.
       Full Text  Link to Item
    • Johnatty, S. E., J. Beesley, X. Chen, S. Macgregor, D. L. Duffy, A. B. Spurdle, A. deFazio, et al. “Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".” Plos Genetics 6, no. 7 (July 1, 2010).
    • Kelemen, Linda E., Marc T. Goodman, Valerie McGuire, Mary Anne Rossing, Penelope M. Webb, Penelope M. Australian Cancer Study (Ovarian Cancer) Study Group, Martin Köbel, et al. “Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.” Cancer Epidemiol Biomarkers Prev 19, no. 7 (July 2010): 1822–30. https://doi.org/10.1158/1055-9965.EPI-09-1317.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Edwin S. Iversen, Melanie A. Wilson, Merlise A. Clyde, Patricia G. Moorman, Rachel T. Palmieri, Regina Whitaker, Rex C. Bentley, Jeffrey R. Marks, and Andrew Berchuck. “Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.” Plos One 5, no. 4 (April 8, 2010): e10061. https://doi.org/10.1371/journal.pone.0010061.
       Full Text  Open Access Copy
    • Goode, Ellen L., Matthew J. Maurer, Thomas A. Sellers, Catherine M. Phelan, Kimberly R. Kalli, Brooke L. Fridley, Robert A. Vierkant, et al. “Inherited determinants of ovarian cancer survival.” Clin Cancer Res 16, no. 3 (February 1, 2010): 995–1007. https://doi.org/10.1158/1078-0432.CCR-09-2553.
       Full Text  Link to Item
    • Phelan, Catherine M., Ya-Yu Tsai, Ellen L. Goode, Robert A. Vierkant, Brooke L. Fridley, Jonathan Beesley, Xiao Qing Chen, et al. “Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.” Cancer Epidemiol Biomarkers Prev 19, no. 2 (February 2010): 600–604. https://doi.org/10.1158/1055-9965.EPI-09-0861.
       Full Text  Link to Item
    • White, Kristin L., Thomas A. Sellers, Brooke L. Fridley, Robert A. Vierkant, Catherine M. Phelan, Ya-Yu Tsai, Kimberly R. Kalli, et al. “Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.” Twin Res Hum Genet 13, no. 1 (February 2010): 43–56. https://doi.org/10.1375/twin.13.1.43.
       Full Text  Link to Item
    • Peedicayil, Abraham, Robert A. Vierkant, Lynn C. Hartmann, Brooke L. Fridley, Zachary S. Fredericksen, Kristin L. White, Elaine A. Elliott, et al. “Risk of ovarian cancer and inherited variants in relapse-associated genes.” Plos One 5, no. 1 (January 27, 2010): e8884. https://doi.org/10.1371/journal.pone.0008884.
       Full Text  Open Access Copy  Link to Item
    • Doherty, Jennifer A., Mary Anne Rossing, Kara L. Cushing-Haugen, Chu Chen, David J. Van Den Berg, Anna H. Wu, Malcolm C. Pike, et al. “ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.” Cancer Epidemiol Biomarkers Prev 19, no. 1 (January 2010): 245–50. https://doi.org/10.1158/1055-9965.EPI-09-0729.
       Full Text  Link to Item
    • Hoyo, Cathrine, Joellen M. Schildkraut, Susan K. Murphy, Wong-Ho Chow, Thomas L. Vaughan, Harvey Risch, Jeffrey R. Marks, et al. “IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.” Int J Cancer 125, no. 11 (December 1, 2009): 2673–78. https://doi.org/10.1002/ijc.24623.
       Full Text  Link to Item
    • Pearce, C. L., A. M. Near, D. J. Van Den Berg, S. J. Ramus, A. Gentry-Maharaj, U. Menon, S. A. Gayther, et al. “Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com).” British Journal of Cancer 101, no. 10 (November 1, 2009): 1805. https://doi.org/10.1038/sj.bjc.6605431.
       Full Text
    • Cunningham, J. M., R. A. Vierkant, T. A. Sellers, C. Phelan, D. N. Rider, M. Liebow, J. Schildkraut, et al. “Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.” Br J Cancer 101, no. 8 (October 20, 2009): 1461–68. https://doi.org/10.1038/sj.bjc.6605284.
       Full Text  Link to Item
    • Moorman, Patricia G., Rachel T. Palmieri, Lucy Akushevich, Andrew Berchuck, and Joellen M. Schildkraut. “Ovarian cancer risk factors in African-American and white women.” Am J Epidemiol 170, no. 5 (September 1, 2009): 598–606. https://doi.org/10.1093/aje/kwp176.
       Full Text  Link to Item
    • Song, Honglin, Susan J. Ramus, Jonathan Tyrer, Kelly L. Bolton, Aleksandra Gentry-Maharaj, Eva Wozniak, Hoda Anton-Culver, et al. “A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.” Nat Genet 41, no. 9 (September 2009): 996–1000. https://doi.org/10.1038/ng.424.
       Full Text  Link to Item
    • Peedicayil, Abraham, Robert A. Vierkant, Vijayalakshmi Shridhar, Joellen M. Schildkraut, Sebastian Armasu, Lynn C. Hartmann, Brooke L. Fridley, et al. “Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.” Gynecol Oncol 114, no. 2 (August 2009): 260–64. https://doi.org/10.1016/j.ygyno.2009.03.038.
       Full Text  Link to Item
    • Hoyo, Cathrine, Janet Grubber, Wendy Demark-Wahnefried, Bruce Lobaugh, Amy S. Jeffreys, Steven C. Grambow, Jeffrey R. Marks, Temitope O. Keku, Phillip J. Walther, and Joellen M. Schildkraut. “Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.” J Natl Med Assoc 101, no. 7 (July 2009): 711–16. https://doi.org/10.1016/s0027-9684(15)30981-0.
       Full Text  Link to Item
    • Quaye, Lydia, Jonathan Tyrer, Susan J. Ramus, Honglin Song, Eva Wozniak, Richard A. DiCioccio, Valerie McGuire, et al. “Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.” Plos One 4, no. 6 (June 19, 2009): e5983. https://doi.org/10.1371/journal.pone.0005983.
       Full Text  Link to Item
    • Song, Honglin, Susan J. Ramus, Susanne Krüger Kjaer, Richard A. DiCioccio, Georgia Chenevix-Trench, Celeste Leigh Pearce, Estrid Hogdall, et al. “Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.” Hum Mol Genet 18, no. 12 (June 15, 2009): 2297–2304. https://doi.org/10.1093/hmg/ddp138.
       Full Text  Link to Item
    • White, Kristin L., Robert A. Vierkant, Catherine M. Phelan, Brooke L. Fridley, Stephanie Anderson, Keith L. Knutson, Joellen M. Schildkraut, et al. “Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.” Bmc Cancer 9 (June 6, 2009): 170. https://doi.org/10.1186/1471-2407-9-170.
       Full Text  Link to Item
    • Moorman, Patricia G., Joellen M. Schildkraut, Edwin S. Iversen, Evan R. Myers, Margaret Gradison, Nicolette Warren-White, and Frances Wang. “A prospective study of weight gain after premenopausal hysterectomy.” J Womens Health (Larchmt) 18, no. 5 (May 2009): 699–708. https://doi.org/10.1089/jwh.2008.1019.
       Full Text  Link to Item
    • Fasching, Peter A., Simon Gayther, Leigh Pearce, Joellen M. Schildkraut, Ellen Goode, Falk Thiel, Georgia Chenevix-Trench, et al. “Role of genetic polymorphisms and ovarian cancer susceptibility.” Mol Oncol 3, no. 2 (April 2009): 171–81. https://doi.org/10.1016/j.molonc.2009.01.008.
       Full Text  Link to Item
    • Il’yasova, Dora, Bridget McCarthy, Jennifer Marcello, Joellen M. Schildkraut, Patricia G. Moorman, Bhuma Krishnamachari, Francis Ali-Osman, Darell D. Bigner, and Faith Davis. “Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls.” Cancer Epidemiol Biomarkers Prev 18, no. 4 (April 2009): 1232–38. https://doi.org/10.1158/1055-9965.EPI-08-0995.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Ellen L. Goode, Merlise A. Clyde, Edwin S. Iversen, Patricia G. Moorman, Andrew Berchuck, Jeffrey R. Marks, et al. “Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.” Cancer Res 69, no. 6 (March 15, 2009): 2349–57. https://doi.org/10.1158/0008-5472.CAN-08-2902.
       Full Text  Link to Item
    • Goode, Ellen L., Brooke L. Fridley, Robert A. Vierkant, Julie M. Cunningham, Catherine M. Phelan, Stephanie Anderson, David N. Rider, et al. “Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.” Cancer Epidemiol Biomarkers Prev 18, no. 3 (March 2009): 935–44. https://doi.org/10.1158/1055-9965.EPI-08-0860.
       Full Text  Link to Item
    • Pearce, C. L., A. M. Near, D. J. Van Den Berg, S. J. Ramus, A. Gentry-Maharaj, U. Menon, S. A. Gayther, et al. “Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.” Br J Cancer 100, no. 2 (January 27, 2009): 412–20. https://doi.org/10.1038/sj.bjc.6604820.
       Full Text  Link to Item
    • Pearce, C. L., A. M. Near, D. J. Van Den Berg, S. J. Ramus, A. Gentry-Maharaj, U. Menon, S. A. Gayther, et al. “Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.” British Journal of Cancer 100, no. 2 (January 27, 2009): 412–20. https://doi.org/10.1038/sj.bjc.6604820.
       Full Text
    • Buchanan, A. H., C. S. Skinner, B. Calingaert, J. M. Schildkraut, R. H. King, and P. K. Marcom. “Cancer genetic counseling in rural north carolina oncology clinics: Program establishment and patient characteristics.” Community Oncology 6, no. 2 (January 1, 2009): 70–77. https://doi.org/10.1016/S1548-5315(11)70213-3.
       Full Text
    • Permuth-Wey, Jenny, David Boulware, Nikola Valkov, Sandra Livingston, Santo Nicosia, Ji-Hyun Lee, Rebecca Sutphen, et al. “Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.” Cancer Epidemiol Biomarkers Prev 18, no. 1 (January 2009): 28–34. https://doi.org/10.1158/1055-9965.EPI-08-0713.
       Full Text  Link to Item
    • Palmieri, Rachel T., Melanie A. Wilson, Edwin S. Iversen, Merlise A. Clyde, Brian Calingaert, Patricia G. Moorman, Charles Poole, et al. “Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.” Cancer Epidemiol Biomarkers Prev 17, no. 12 (December 2008): 3567–72. https://doi.org/10.1158/1055-9965.EPI-08-0548.
       Full Text  Link to Item
    • Neklason, Deborah W., Richard A. Kerber, David B. Nilson, Hoda Anton-Culver, Ann G. Schwartz, Constance A. Griffin, Jan T. Lowery, et al. “Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.” Cancer Res 68, no. 21 (November 1, 2008): 8993–97. https://doi.org/10.1158/0008-5472.CAN-08-1376.
       Full Text  Link to Item
    • Potthoff, Richard F., Susan Halabi, Joellen M. Schildkraut, and Beth Newman. “Flexible Frames and Control Sampling in Case-Control Studies: Weighters (Survey Statisticians) Versus Anti-Weighters (Epidemiologists).” Am Stat 62, no. 4 (November 1, 2008): 307–13. https://doi.org/10.1198/000313008X364525.
       Full Text  Link to Item
    • Ramus, Susan J., Robert A. Vierkant, Sharon E. Johnatty, Malcolm C. Pike, David J. Van Den Berg, Anna H. Wu, Celeste Leigh Pearce, et al. “Consortium analysis of 7 candidate SNPs for ovarian cancer.” Int J Cancer 123, no. 2 (July 15, 2008): 380–88. https://doi.org/10.1002/ijc.23448.
       Full Text  Link to Item
    • Cunningham, Julie M., Thomas A. Sellers, Joellen M. Schildkraut, Zachary S. Fredericksen, Robert A. Vierkant, Linda E. Kelemen, Madhura Gadre, et al. “Performance of amplified DNA in an Illumina GoldenGate BeadArray assay.” Cancer Epidemiol Biomarkers Prev 17, no. 7 (July 2008): 1781–89. https://doi.org/10.1158/1055-9965.EPI-07-2849.
       Full Text  Link to Item
    • Risch, Harvey A. “Cyclin E overexpression relates to ovarian cancer histology but not to risk factors.” Cancer Epidemiol Biomarkers Prev 17, no. 7 (July 2008): 1841. https://doi.org/10.1158/1055-9965.EPI-08-0271.
       Full Text  Link to Item
    • Moorman, Patricia G., Brian Calingaert, Rachel T. Palmieri, Edwin S. Iversen, Rex C. Bentley, Susan Halabi, Andrew Berchuck, and Joellen M. Schildkraut. “Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.” Am J Epidemiol 167, no. 9 (May 1, 2008): 1059–69. https://doi.org/10.1093/aje/kwn006.
       Full Text  Link to Item
    • Kelemen, Linda E., Thomas A. Sellers, Joellen M. Schildkraut, Julie M. Cunningham, Robert A. Vierkant, V Shane Pankratz, Zachary S. Fredericksen, et al. “Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.” Cancer Res 68, no. 7 (April 1, 2008): 2498–2506. https://doi.org/10.1158/0008-5472.CAN-07-5165.
       Full Text  Link to Item
    • Barnett, J. C., A. Bland, R. Whitaker, B. Calingaert, R. C. Bentley, P. S. Lee, P. C. Moorman, J. M. Schildkraut, and A. Berchuck. “The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study.” Gynecologic Oncology 108, no. 3 (March 2008): S125–S125.
       Link to Item
    • Ramus, S. J., R. A. Vierkant, S. Jonhatty, J. M. Schildkraut, P. D. Pharoah, G. Chenevix-Trench, C. L. Pearce, A. Berchuck, and E. L. Goode. “Ovarian Cancer Association Consortium analysis of seven candidate ovarian cancer susceptibility polymorphisms.” Gynecologic Oncology 108, no. 3 (March 1, 2008): S29–30.
       Link to Item
    • Schildkraut, Joellen M., Patricia G. Moorman, Amy E. Bland, Susan Halabi, Brian Calingaert, Regina Whitaker, Paula S. Lee, et al. “Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.” Cancer Epidemiol Biomarkers Prev 17, no. 3 (March 2008): 585–93. https://doi.org/10.1158/1055-9965.EPI-07-0596.
       Full Text  Link to Item
    • Sellers, Thomas A., Yifan Huang, Julie Cunningham, Ellen L. Goode, Rebecca Sutphen, Robert A. Vierkant, Linda E. Kelemen, et al. “Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.” Cancer Epidemiol Biomarkers Prev 17, no. 2 (February 2008): 397–404. https://doi.org/10.1158/1055-9965.EPI-07-0565.
       Full Text  Link to Item
    • Pearce, C. L., A. H. Wu, S. A. Gayther, A. E. Bale, A. E. Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group, P. A. Beck, J. Beesley, et al. “Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.” Br J Cancer 98, no. 2 (January 29, 2008): 282–88. https://doi.org/10.1038/sj.bjc.6604170.
       Full Text  Link to Item
    • Berchuck, Andrew, Joellen M. Schildkraut, C Leigh Pearce, Georgia Chenevix-Trench, and Paul D. Pharoah. “Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium.” Adv Exp Med Biol 622 (2008): 53–67. https://doi.org/10.1007/978-0-387-68969-2_5.
       Full Text  Link to Item
    • Potthoff, Richard F., Susan Halabi, Joellen M. Schildkraut, and Beth Newman. “Flexible Frames and Control Sampling in Case-Control Studies.” The American Statistician 62, no. 4 (2008): 307–13.
    • Skinner, C. S., J. M. Schildkraut, B. Calingaert, C. Hoyo, S. S. Crankshaw, L. Fish, L. Susswein, C. Jasper, and L. Reid. “Factors associated with African Americans' enrollment in a national cancer genetics registry.” Community Genet 11, no. 4 (2008): 224–33. https://doi.org/10.1159/000116883.
       Full Text  Link to Item
    • Parmigiani, Giovanni, Sining Chen, Edwin S. Iversen, Tara M. Friebel, Dianne M. Finkelstein, Hoda Anton-Culver, Argyrios Ziogas, et al. “Validity of models for predicting BRCA1 and BRCA2 mutations.” Ann Intern Med 147, no. 7 (October 2, 2007): 441–50. https://doi.org/10.7326/0003-4819-147-7-200710020-00002.
       Full Text  Link to Item
    • Claus, Elizabeth B., Peter M. Black, Melissa L. Bondy, Lisa Calvocoressi, Joellen M. Schildkraut, Joseph L. Wiemels, and Margaret Wrensch. “Exogenous hormone use and meningioma risk: what do we tell our patients?” Cancer 110, no. 3 (August 1, 2007): 471–76. https://doi.org/10.1002/cncr.22783.
       Full Text  Link to Item
    • Hoyo, Cathrine, Janet Grubber, Wendy Demark-Wahnefried, Jeffrey R. Marks, Stephen J. Freedland, Amy S. Jeffreys, Steven C. Grambow, Robert M. Wenham, Philip J. Walther, and Joellen M. Schildkraut. “Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites.” J Natl Med Assoc 99, no. 7 (July 2007): 718–22.
       Link to Item
    • Gayther, Simon A., Honglin Song, Susan J. Ramus, Susan Krüger Kjaer, Alice S. Whittemore, Lydia Quaye, Jonathan Tyrer, et al. “Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.” Cancer Res 67, no. 7 (April 1, 2007): 3027–35. https://doi.org/10.1158/0008-5472.CAN-06-3261.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Susan K. Murphy, Rachel T. Palmieri, Edwin Iversen, Patricia G. Moorman, Zhiqing Huang, Susan Halabi, et al. “Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.” Cancer Epidemiol Biomarkers Prev 16, no. 3 (March 2007): 473–80. https://doi.org/10.1158/1055-9965.EPI-06-0868.
       Full Text  Link to Item
    • Maxwell, G. L., J. M. Schildkraut, B. Calingaert, J. I. Risinger, L. Dainty, P. A. Marchbanks, A. Berchuck, J. C. Barrett, and G. C. Rodriguez. “Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.” Gynecol Oncol 103, no. 2 (November 2006): 535–40. https://doi.org/10.1016/j.ygyno.2006.03.046.
       Full Text  Link to Item
    • Lancaster, J. M., R. A. Sayer, C. Blanchette, B. Calingaert, I. Konidari, J. Gray, J. Schildkraut, D. W. Schomberg, J. R. Marks, and A. Berchuck. “High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels.” Int J Gynecol Cancer 16, no. 4 (July 2006): 1529–35. https://doi.org/10.1111/j.1525-1438.2006.00623.x.
       Full Text  Link to Item
    • Chen, Sining, Edwin S. Iversen, Tara Friebel, Dianne Finkelstein, Barbara L. Weber, Andrea Eisen, Leif E. Peterson, et al. “Characterization of BRCA1 and BRCA2 mutations in a large United States sample.” J Clin Oncol 24, no. 6 (February 20, 2006): 863–71. https://doi.org/10.1200/JCO.2005.03.6772.
       Full Text  Link to Item
    • Matthews, Abigail G., Rebecca A. Betensky, Hoda Anton-Culver, Deborah Bowen, Constance Griffin, Claudine Isaacs, Carol Kasten, et al. “Analysis of co-aggregation of cancer based on registry data.” Community Genet 9, no. 2 (2006): 87–92. https://doi.org/10.1159/000091485.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Patricia G. Moorman, Susan Halabi, Brian Calingaert, Jeffrey R. Marks, and Andrew Berchuck. “Analgesic drug use and risk of ovarian cancer.” Epidemiology 17, no. 1 (January 2006): 104–7. https://doi.org/10.1097/01.ede.0000190538.55645.f8.
       Full Text  Link to Item
    • Claus, Elizabeth B., Melissa L. Bondy, Joellen M. Schildkraut, Joseph L. Wiemels, Margaret Wrensch, and Peter M. Black. “Epidemiology of intracranial meningioma.” Neurosurgery 57, no. 6 (December 2005): 1088–95. https://doi.org/10.1227/01.neu.0000188281.91351.b9.
       Full Text  Link to Item
    • Sellers, Thomas A., Joellen M. Schildkraut, V Shane Pankratz, Robert A. Vierkant, Zachary S. Fredericksen, Janet E. Olson, Julie Cunningham, et al. “Estrogen bioactivation, genetic polymorphisms, and ovarian cancer.” Cancer Epidemiol Biomarkers Prev 14, no. 11 Pt 1 (November 2005): 2536–43. https://doi.org/10.1158/1055-9965.EPI-05-0142.
       Full Text  Link to Item
    • Scott, W. K., and J. M. Schildkraut. “Complex Genetic Interactions,” October 7, 2005, 397–421. https://doi.org/10.1002/9780471781141.ch14.
       Full Text
    • Hoyo, Cathrine, Andrew Berchuck, Susan Halabi, Rex C. Bentley, Patricia Moorman, Brian Calingaert, and Joellen M. Schildkraut. “Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women.” Cancer Causes Control 16, no. 8 (October 2005): 955–63. https://doi.org/10.1007/s10552-005-3205-y.
       Full Text  Link to Item
    • Moorman, Patricia G., Joellen M. Schildkraut, Brian Calingaert, Susan Halabi, and Andrew Berchuck. “Menopausal hormones and risk of ovarian cancer.” Am J Obstet Gynecol 193, no. 1 (July 2005): 76–82. https://doi.org/10.1016/j.ajog.2004.11.013.
       Full Text  Link to Item
    • Kelemen, Livia, Michael James, Amanda Spurdle, Ian Campbell, Jenny Chang-Claude, David Peel, Hoda Anton-Culver, et al. “BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.” Gynecol Oncol 97, no. 3 (June 2005): 807–12. https://doi.org/10.1016/j.ygyno.2005.03.007.
       Full Text  Link to Item
    • Spillman, Monique A., Joellen M. Schildkraut, Susan Halabi, Patricia Moorman, Brian Calingaert, Rex C. Bentley, Jeffrey R. Marks, Susan Murphy, and Andrew Berchuck. “Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.” Gynecol Oncol 97, no. 2 (May 2005): 543–49. https://doi.org/10.1016/j.ygyno.2005.01.025.
       Full Text  Link to Item
    • Moorman, Patricia G., Andrew Berchuck, Brian Calingaert, Susan Halabi, and Joellen M. Schildkraut. “Antidepressant medication use [corrected] and risk of ovarian cancer.” Obstet Gynecol 105, no. 4 (April 2005): 725–30. https://doi.org/10.1097/01.AOG.0000157113.98061.eb.
       Full Text  Link to Item
    • Skinner, Celette Sugg, Susan M. Rawl, Barry K. Moser, Adam H. Buchanan, Linda L. Scott, Victoria L. Champion, Joellen M. Schildkraut, et al. “Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.” J Gen Intern Med 20, no. 4 (April 2005): 360–65. https://doi.org/10.1111/j.1525-1497.2005.40115.x.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Wendy Demark-Wahnefried, Robert M. Wenham, Janet Grubber, Amy S. Jeffreys, Steven C. Grambow, Jeffrey R. Marks, et al. “IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.” Cancer Epidemiol Biomarkers Prev 14, no. 2 (February 2005): 403–8. https://doi.org/10.1158/1055-9965.EPI-04-0426.
       Full Text  Link to Item
    • Vanbeek, Marta J., John S. Strauss, and Ingrid Nygaard. “Flushing and papules in a middle-aged woman.” Obstet Gynecol 105, no. 2 (February 2005): 397–401. https://doi.org/10.1097/01.AOG.0000151956.00804.78.
       Full Text  Link to Item
    • Berchuck, Andrew, Joellen M. Schildkraut, Robert M. Wenham, Brian Calingaert, Shazia Ali, Amy Henriott, Susan Halabi, et al. “Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.” Cancer Epidemiol Biomarkers Prev 13, no. 12 (December 2004): 2141–47.
       Link to Item
    • Modugno, Francesmary, Roberta B. Ness, Glenn O. Allen, Joellen M. Schildkraut, Faith G. Davis, and Marc T. Goodman. “Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.” Am J Obstet Gynecol 191, no. 3 (September 2004): 733–40. https://doi.org/10.1016/j.ajog.2004.03.035.
       Full Text  Link to Item
    • Moorman, Patricia G., Celette Sugg Skinner, James P. Evans, Beth Newman, James R. Sorenson, Brian Calingaert, Lisa Susswein, T Sydnee Crankshaw, Cathrine Hoyo, and Joellen M. Schildkraut. “Racial differences in enrolment in a cancer genetics registry.” Cancer Epidemiol Biomarkers Prev 13, no. 8 (August 2004): 1349–54.
       Link to Item
    • Wenham, Robert M., Joellen M. Schildkraut, Kia McLean, Brian Calingaert, Rex C. Bentley, Jeffrey Marks, and Andrew Berchuck. “Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.” Clin Cancer Res 9, no. 12 (October 1, 2003): 4396–4403.
       Link to Item
    • Wenham, Robert M., Brian Calingaert, Shazia Ali, Kia McClean, Regina Whitaker, Rex Bentley, Johnathan M. Lancaster, Joellen Schildkraut, Jeffrey Marks, and Andrew Berchuck. “Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.” J Soc Gynecol Investig 10, no. 6 (September 2003): 381–87. https://doi.org/10.1016/s1071-5576(03)00141-2.
       Full Text  Link to Item
    • Vine, Marilyn F., Brian Calingaert, Andrew Berchuck, and Joellen M. Schildkraut. “Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls.” Gynecol Oncol 90, no. 1 (July 2003): 75–82. https://doi.org/10.1016/s0090-8258(03)00175-6.
       Full Text  Link to Item
    • Lancaster, Johnathan M., Robert M. Wenham, Susan Halabi, Brian Calingaert, Jeffrey R. Marks, Patricia G. Moorman, Rex C. Bentley, Andrew Berchuck, and Joellen M. Schildkraut. “No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.” Cancer Epidemiol Biomarkers Prev 12, no. 3 (March 2003): 226–27.
       Link to Item
    • Lancaster, Johnathan M., Robyn Sayer, Carrie Blanchette, Brian Calingaert, Regina Whitaker, Joellen Schildkraut, Jeffrey Marks, and Andrew Berchuck. “High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival.” Clin Cancer Res 9, no. 2 (February 2003): 762–66.
       Link to Item
    • Anton-Culver, Hoda, Argyrios Ziogas, Deborah Bowen, Dianne Finkelstein, Constance Griffin, James Hanson, Claudine Isaacs, et al. “The Cancer Genetics Network: recruitment results and pilot studies.” Community Genet 6, no. 3 (2003): 171–77. https://doi.org/10.1159/000078165.
       Full Text  Link to Item
    • Moorman, Patricia G., Joellen M. Schildkraut, Brian Calingaert, Susan Halabi, Marilyn F. Vine, and Andrew Berchuck. “Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).” Cancer Causes Control 13, no. 9 (November 2002): 807–11. https://doi.org/10.1023/a:1020678100977.
       Full Text  Link to Item
    • Schildkraut, Joellen M., Brian Calingaert, Polly A. Marchbanks, Patricia G. Moorman, and Gustavo C. Rodriguez. “Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.” J Natl Cancer Inst 94, no. 1 (January 2, 2002): 32–38. https://doi.org/10.1093/jnci/94.1.32.
       Full Text  Link to Item
    • Skinner, Celette Sugg, Joellen M. Schildkraut, Donald Berry, Brian Calingaert, P Kelly Marcom, Jeremy Sugarman, Eric P. Winer, J Dirk Iglehart, P Andrew Futreal, and Barbara K. Rimer. “Pre-counseling education materials for BRCA testing: does tailoring make a difference?” Genet Test 6, no. 2 (2002): 93–105. https://doi.org/10.1089/10906570260199348.
       Full Text  Link to Item
    • Vine, M. F., R. B. Ness, B. Calingaert, J. M. Schildkraut, and A. Berchuck. “Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor.” Gynecol Oncol 83, no. 3 (December 2001): 466–71. https://doi.org/10.1006/gyno.2001.6411.
       Full Text  Link to Item
    • Schildkraut, J. M., G. S. Cooper, S. Halabi, B. Calingaert, P. Hartge, and A. S. Whittemore. “Age at natural menopause and the risk of epithelial ovarian cancer.” Obstet Gynecol 98, no. 1 (July 2001): 85–90. https://doi.org/10.1016/s0029-7844(01)01388-6.
       Full Text  Link to Item
    • Halabi, S., J. M. Schildkraut, G. S. Cooper, B. Calingaert, P. Hartge, and A. S. Whittemore. “Age at natural menopause and the risk of developing invasive epithelial ovarian cancer.” American Journal of Epidemiology 153, no. 11 (June 1, 2001): S111–S111.
       Link to Item
    • Moorman, P. G., B. Calingaert, M. Vine, S. Halabi, A. Berchuck, and J. M. Schildkraut. “Comparison of two methods for calculating lifetime ovulatory cycles.” American Journal of Epidemiology 153, no. 11 (June 1, 2001): S138–S138.
       Link to Item
    • Vine, M. F., R. B. Ness, B. Calingaert, J. M. Schildkraut, and A. Berchuck. “Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor.” American Journal of Epidemiology 153, no. 11 (June 1, 2001): S112–S112.
       Link to Item
    • Demark-Wahnefried, W., and J. M. Schildkraut. “Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000.” Cancer Epidemiol Biomarkers Prev 10, no. 4 (April 2001): 415–16.
       Link to Item
    • Miron, A., J. M. Schildkraut, B. K. Rimer, E. P. Winer, C. Sugg Skinner, P. A. Futreal, D. Culler, et al. “Testing for hereditary breast and ovarian cancer in the southeastern United States.” Ann Surg 231, no. 5 (May 2000): 624–34. https://doi.org/10.1097/00000658-200005000-00002.
       Full Text  Link to Item
    • Denmark-Wahnefried, W., J. M. Schildkraut, D. Thompson, S. M. Lesko, L. McIntyre, P. Schwingl, D. F. Paulson, C. N. Robertson, E. E. Anderson, and P. J. Walther. “Early onset baldness and prostate cancer risk.” Cancer Epidemiol Biomarkers Prev 9, no. 3 (March 2000): 325–28.
       Link to Item
    • Iversen, E. S., G. Parmigiani, D. A. Berry, and J. M. Schildkraut. “Genetic Susceptibility and Survival: Application to Breast Cancer.” Journal of the American Statistical Association 95, no. 449 (March 1, 2000): 28–42. https://doi.org/10.1080/01621459.2000.10473896.
       Full Text
    • Marchbanks, P. A., H. Wilson, E. Bastos, D. W. Cramer, J. M. Schildkraut, and H. B. Peterson. “Cigarette smoking and epithelial ovarian cancer by histologic type.” Obstet Gynecol 95, no. 2 (February 2000): 255–60. https://doi.org/10.1016/s0029-7844(99)00531-1.
       Full Text  Link to Item
    • Schildkraut, J. M., S. Halabi, E. Bastos, P. A. Marchbanks, J. A. McDonald, and A. Berchuck. “Prognostic factors in early-onset epithelial ovarian cancer: a population-based study.” Obstet Gynecol 95, no. 1 (January 2000): 119–27. https://doi.org/10.1016/s0029-7844(99)00535-9.
       Full Text  Link to Item
    • Berchuck, A., A. Lambers, and J. M. Schildkraut. “Relationship between alterations in the p53 tumor suppressor gene and prognosis of ovarian cancer.” Cme Journal of Gynecologic Oncology 4, no. 2 (December 1, 1999): 215–18.
    • Berchuck, A., J. M. Schildkraut, J. R. Marks, and P. A. Futreal. “Managing hereditary ovarian cancer risk.” Cancer 86, no. 11 Suppl (December 1, 1999): 2517–24. https://doi.org/10.1002/(sici)1097-0142(19991201)86:11+<2517::aid-cncr8>3.0.co;2-b.
       Full Text  Link to Item
    • Cooper, G. S., J. M. Schildkraut, A. S. Whittemore, and P. A. Marchbanks. “Pregnancy recency and risk of ovarian cancer.” Cancer Causes Control 10, no. 5 (October 1999): 397–402. https://doi.org/10.1023/a:1008960520316.
       Full Text  Link to Item
    • Janowsky, E. C., G. E. Lester, C. R. Weinberg, R. C. Millikan, J. M. Schildkraut, P. A. Garrett, and B. S. Hulka. “Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk.” Public Health Nutr 2, no. 3 (September 1999): 283–91. https://doi.org/10.1017/s1368980099000385.
       Full Text  Link to Item
    • Müller, P., G. Parmigiani, J. Schildkraut, and L. Tardella. “A Bayesian hierarchical approach for combining case-control and prospective studies.” Biometrics 55, no. 3 (September 1999): 858–66. https://doi.org/10.1111/j.0006-341x.1999.00858.x.
       Full Text  Link to Item
    • Sugarman, J., K. Regan, B. Parker, L. G. Bluman, and J. Schildkraut. “Ethical ramifications of alternative means of recruiting research participants from cancer registries.” Cancer 86, no. 4 (August 15, 1999): 647–51. https://doi.org/10.1002/(sici)1097-0142(19990815)86:4<647::aid-cncr13>3.0.co;2-g.
       Full Text  Link to Item
    • Conlisk, E. A., E. J. Lengerich, W. Demark-Wahnefried, J. M. Schildkraut, and T. E. Aldrich. “Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina.” Urology 53, no. 6 (June 1999): 1194–99. https://doi.org/10.1016/s0090-4295(99)00005-9.
       Full Text  Link to Item
    • Bluman, L. G., B. K. Rimer, D. A. Berry, N. Borstelmann, J. D. Iglehart, K. Regan, J. Schildkraut, and E. P. Winer. “Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.” J Clin Oncol 17, no. 3 (March 1999): 1040–46. https://doi.org/10.1200/JCO.1999.17.3.1040.
       Full Text  Link to Item
    • Schildkraut, J. M., W. Demark-Wahnefried, E. DeVoto, C. Hughes, J. L. Laseter, and B. Newman. “Environmental contaminants and body fat distribution.” Cancer Epidemiol Biomarkers Prev 8, no. 2 (February 1999): 179–83.
       Link to Item
    • Berchuck, A., J. M. Schildkraut, J. R. Marks, and P. A. Futreal. “Managing hereditary ovarian cancer risk.” Cancer 86, no. 8 SUPPL. (1999): 1697–1704.
    • Sugarman, J., K. Regan, B. Parker, L. G. Bluman, and J. Schildkraut. “Erratum: Ethical ramifications of alternative means of recruiting research participants from cancer registries (Cancer (1999) 86 (647-651)).” Cancer 86, no. 12 (1999): 2707-. https://doi.org/10.1002/(SICI)1097-0142(19991215)86:12<2707::AID-CNCR15>3.0.CO;2-L.
       Full Text
    • Claus, E. B., J. Schildkraut, E. S. Iversen, D. Berry, and G. Parmigiani. “Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.” J Natl Cancer Inst 90, no. 23 (December 2, 1998): 1824–29. https://doi.org/10.1093/jnci/90.23.1824.
       Full Text  Link to Item
    • Demark-Wahnefried, W., J. M. Schildkraut, C. E. Iselin, E. Conlisk, A. Kavee, T. E. Aldrich, E. J. Lengerich, P. J. Walther, and D. F. Paulson. “Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina.” Cancer 83, no. 2 (July 15, 1998): 320–30. https://doi.org/10.1002/(sici)1097-0142(19980715)83:2<320::aid-cncr16>3.0.co;2-v.
       Full Text  Link to Item
    • Cooper, G. S., J. M. Schildkraut, and A. S. Whittemore. “Pregnancy regency, menopausal status, and risk of ovarian cancer.” American Journal of Epidemiology 147, no. 11 (June 1, 1998): S90–S90.
       Link to Item
    • Audrain, J., B. Rimer, D. Cella, J. Garber, B. N. Peshkin, J. Ellis, J. Schildkraut, M. Stefanek, V. Vogel, and C. Lerman. “Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?” J Clin Oncol 16, no. 1 (January 1998): 133–38. https://doi.org/10.1200/JCO.1998.16.1.133.
       Full Text  Link to Item
    • Steinberg, K. K., J. M. Pernarelli, M. Marcus, M. J. Khoury, J. M. Schildkraut, and P. A. Marchbanks. “Increased risk for familial ovarian cancer among Jewish women: a population-based case-control study.” Genet Epidemiol 15, no. 1 (1998): 51–59. https://doi.org/10.1002/(SICI)1098-2272(1998)15:1<51::AID-GEPI4>3.0.CO;2-7.
       Full Text  Link to Item
    • Schildkraut, J. M., E. Bastos, S. Halabi, and A. Berchuck. “Response.” Jnci Journal of the National Cancer Institute 89, no. 22 (November 19, 1997): 1727–1727. https://doi.org/10.1093/jnci/89.22.1727.
       Full Text
    • Berchuck, A., and J. Schildkraut. “Oral contraceptive pills. Prevention of ovarian cancer and other benefits.” N C Med J 58, no. 6 (November 1997): 404–7.
       Link to Item
    • Schildkraut, J. M., E. Bastos, and A. Berchuck. “Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.” J Natl Cancer Inst 89, no. 13 (July 2, 1997): 932–38. https://doi.org/10.1093/jnci/89.13.932.
       Full Text  Link to Item
    • Berry, D. A., G. Parmigiani, J. Sanchez, J. Schildkraut, and E. Winer. “Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.” J Natl Cancer Inst 89, no. 3 (February 5, 1997): 227–38. https://doi.org/10.1093/jnci/89.3.227.
       Full Text  Link to Item
    • Haines, J. L., M. L. Pritchard, A. M. Saunders, J. M. Schildkraut, J. H. Growdon, P. C. Gaskell, L. A. Farrer, et al. “No association between alpha 1-antichymotrypsin and familial Alzheimer's disease.” Ann N Y Acad Sci 802 (December 16, 1996): 35–41. https://doi.org/10.1111/j.1749-6632.1996.tb32596.x.
       Full Text  Link to Item
    • Abu-Rustum, N. R., R. R. Barakat, P. L. Siegel, E. Venkatraman, J. P. Curtin, and W. J. Hoskins. “Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy?” Obstet Gynecol 88, no. 4 Pt 1 (October 1996): 549–53. https://doi.org/10.1016/0029-7844(96)00265-7.
       Full Text  Link to Item
    • Schildkraut, J. M., P. J. Schwingl, E. Bastos, A. Evanoff, and C. Hughes. “Epithelial ovarian cancer risk among women with polycystic ovary syndrome.” Obstet Gynecol 88, no. 4 Pt 1 (October 1996): 554–59. https://doi.org/10.1016/0029-7844(96)00226-8.
       Full Text  Link to Item
    • Berchuck, A., F. Cirisano, J. M. Lancaster, J. M. Schildkraut, R. W. Wiseman, A. Futreal, and J. R. Marks. “Role of BRCA1 mutation screening in the management of familial ovarian cancer.” Am J Obstet Gynecol 175, no. 3 Pt 1 (September 1996): 738–46. https://doi.org/10.1053/ob.1996.v175.a74288.
       Full Text  Link to Item
    • Berchuck, A., F. Cirisano, J. M. Lancaster, J. M. Schildkraut, R. W. Wiseman, A. Futreal, and J. R. Marks. “Role of BRCA1 mutation screening in the management of familial ovarian cancer.” American Journal of Obstetrics and Gynecology 175, no. 3 (September 1996): 738–46.
       Link to Item
    • Claus, E. B., J. M. Schildkraut, W. D. Thompson, and N. J. Risch. “The genetic attributable risk of breast and ovarian cancer.” Cancer 77, no. 11 (June 1, 1996): 2318–24. https://doi.org/10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z.
       Full Text  Link to Item
    • Rimer, B. K., J. M. Schildkraut, C. Lerman, T. H. Lin, and J. Audrain. “Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium.” Cancer 77, no. 11 (June 1, 1996): 2348–55. https://doi.org/10.1002/(SICI)1097-0142(19960601)77:11<2348::AID-CNCR25>3.0.CO;2-W.
       Full Text  Link to Item
    • Haines, J. L., M. L. Pritchard, A. M. Saunders, J. M. Schildkraut, J. H. Growdon, P. C. Gaskell, L. A. Farrer, et al. “No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.” Genomics 33, no. 1 (April 1, 1996): 53–56. https://doi.org/10.1006/geno.1996.0158.
       Full Text  Link to Item
    • Suris-Swartz, P. J., J. M. Schildkraut, M. F. Vine, and I. Hertz-Picciotto. “Age at diagnosis and multiple primary cancers of the breast and ovary.” Breast Cancer Res Treat 41, no. 1 (1996): 21–29. https://doi.org/10.1007/BF01807033.
       Full Text  Link to Item
    • Schildkraut, J. M., N. K. Collins, G. A. Dent, J. A. Tucker, J. C. Barrett, A. Berchuck, and J. Boyd. “Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer.” Am J Obstet Gynecol 172, no. 3 (March 1995): 908–13. https://doi.org/10.1016/0002-9378(95)90020-9.
       Full Text  Link to Item
    • Aldrich, T., W. Demark-Wahnefried, J. M. Schildkraut, E. Lengerich, and E. Conlísk. “The National Cancer Data Base report on prostate cancer.” Cancer 75, no. 1 (January 1, 1995): 136–38. https://doi.org/10.1002/1097-0142(19950101)75:1<136::aid-cncr2820750126>3.0.co;2-3.
       Full Text  Link to Item
    • Schildkraut, J. M., C. Lerman, E. Lustbader, and B. K. Rimer. “Adherence to mammography among subgroups of women at high risk for breast cancer.” Journal of Women’S Health 4, no. 6 (January 1, 1995): 645–54. https://doi.org/10.1089/jwh.1995.4.645.
       Full Text
    • CLAUS, E. B., J. M. SCHILDKRAUT, W. D. THOMPSON, and N. J. RISCH. “ANALYSIS OF THE GENETIC-RELATIONSHIP BETWEEN BREAST AND OVARIAN-CANCER.” American Journal of Human Genetics 53, no. 3 (September 1, 1993): 787–787.
       Link to Item
    • Thompson, W. D., and J. M. Schildkraut. “Family history of gynaecological cancers: Relationships to the incidence of breast cancer prior to age 55.” Obstetrical and Gynecological Survey 47, no. 6 (January 1, 1992): 402–5. https://doi.org/10.1097/00006254-199206000-00017.
       Full Text
    • Thompson, W. D., and J. M. Schildkraut. “Family history of gynaecological cancers: relationships to the incidence of breast cancer prior to age 55.” Int J Epidemiol 20, no. 3 (September 1991): 595–602. https://doi.org/10.1093/ije/20.3.595.
       Full Text  Link to Item
    • SCHILDKRAUT, J. M., B. S. HULKA, and W. E. WILKINSON. “ORAL-CONTRACEPTIVES AND BREAST-CANCER - A CASE-CONTROL STUDY WITH HOSPITAL AND COMMUNITY CONTROLS.” Obstetrics and Gynecology 76, no. 3 (September 1, 1990): 395–402.
       Link to Item
    • Schildkraut, J. M., B. S. Hulka, and W. E. Wilkinson. “Oral contraceptives and breast cancer: a case-control study with hospital and community controls.” Obstet Gynecol 76, no. 3 Pt 1 (September 1990): 395–402.
       Link to Item
    • Schildkraut, J. M., B. S. Hulka, and W. E. Wilkinson. “Oral contraceptives and breast cancer: A case-control study with hospital and community controls.” Obstetrics and Gynecology 76, no. 3 (January 1, 1990): 395–402.
    • Schildkraut, J. M., and B. S. Hulka. “Re: Oral contraceptives and breast cancer: A case-control study with hospital and community controls.” Obstetrics and Gynecology 76, no. 6 (January 1, 1990): 1147.
    • Schildkraut, J. M., N. Risch, and W. D. Thompson. “Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship.” Am J Hum Genet 45, no. 4 (October 1989): 521–29.
       Link to Item
    • Schildkraut, J. M., R. H. Myers, L. A. Cupples, D. K. Kiely, and W. B. Kannel. “Coronary risk associated with age and sex of parental heart disease in the Framingham Study.” Am J Cardiol 64, no. 10 (September 15, 1989): 555–59. https://doi.org/10.1016/0002-9149(89)90477-3.
       Full Text  Link to Item
    • Schildkraut, J. M., and W. D. Thompson. “The authors reply.” American Journal of Epidemiology 130, no. 5 (January 1, 1989): 1072–73. https://doi.org/10.1093/oxfordjournals.aje.a115415.
       Full Text
    • Schildkraut, J. M., and W. D. Thompson. “Familial ovarian cancer: a population-based case-control study.” Am J Epidemiol 128, no. 3 (September 1988): 456–66. https://doi.org/10.1093/oxfordjournals.aje.a114994.
       Full Text  Link to Item
    • FLEMING, C., J. M. SCHILDKRAUT, R. B. DAGOSTINO, and H. P. SELKER. “DO EMERGENCY ROOM PHYSICIANS OVERESTIMATE THE IMPORTANCE OF MALE SEX WHEN ADMITTING TO THE CORONARY-CARE UNIT - A MULTICENTER STUDY.” Clinical Research 36, no. 3 (April 1, 1988): A711–A711.
       Link to Item
    • FLEMING, C., J. M. SCHILDKRAUT, R. B. DAGOSTINO, and H. P. SELKER. “DOES AGE INFLUENCE THE CORONARY-CARE UNIT ADMISSION DECISION - A MULTICENTER STUDY.” Clinical Research 36, no. 3 (April 1, 1988): A723–A723.
       Link to Item
    • Schildkraut, J. M., and W. D. Thompson. “Relationship of epithelial ovarian cancer to other malignancies within families.” Genet Epidemiol 5, no. 5 (1988): 355–67. https://doi.org/10.1002/gepi.1370050506.
       Full Text  Link to Item
    • SCHILDKRAUT, J. M. “Granuloma inguinale; carcinoma?” Ama Arch Derm Syphilol 63, no. 3 (March 1951): 399–401.
       Link to Item
    • SCHILDKRAUT, J. M. “Lupus vulgaris.” Arch Derm Syphilol 60, no. 1 (July 1949): 134.
       Link to Item
    • SCHILDKRAUT, J. M. “Epidermodysplasia verruciformis.” Arch Derm Syphilol 57, no. 3 Pt. 2 (March 1948): 414.
       Link to Item
    • SCHILDKRAUT, J. M. “A case for diagnosis (scleroderma; atrophoderma; acrodermatitis atrophicans chronica?).” Arch Derm Syphilol 53 (June 1946): 666.
       Link to Item

  • Book Sections

    • Peres, Lauren C., and Joellen M. Schildkraut. “Racial/ethnic disparities in ovarian cancer research.,” 146:1–21, 2020. https://doi.org/10.1016/bs.acr.2020.01.002.
       Full Text  Link to Item

  • Other Articles

    • Meeks, Huong D., Honglin Song, Kyriaki Michailidou, Manjeet K. Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, et al. “BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.” J Natl Cancer Inst, February 2016. https://doi.org/10.1093/jnci/djv315.
       Full Text  Link to Item
    • Hoyo, C., J. M. Schildkraut, S. K. Murph, W. H. Chow, T. L. Vaughan, H. Risch, J. R. Marks, et al. “IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas (International Journal of Cancer (2009) 125, (2673-2678)).” International Journal of Cancer, February 1, 2010. https://doi.org/10.1002/ijc.24975.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.